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 1 
Abstract 
Epilepsy is regarded as a kind of brain disease caused by the abnormal activities of 
neurons after brain injuries. Long term severe neuron activities, or excitotoxicity, may 
lead to the death of neurons, causing irreversible damage to the brain. Epilepsy is not 
curable and hence its treatment is widely investigated. In this dissertation, in order to 
understand epilepsy, three main projects are undertaken. These projects are: 1) Insulin-
Like Growth Factor-1 (IGF-1) regulation in epileptogenesis; 2) effect of siRNA silencing 
on axon growth; and 3) optical coherence microscopy (OCM) in the study of epilepsy. 
 
The first project is to investigate IGF-1 Signaling in Posttraumatic Epileptogenesis. It is 
reported that concentration of Insulin-like Growth Factor -1 (IGF-1) increases in the brain 
tissue after head injury, and the phosphorylation in the receptor of IGF-1 causes 
activation of mammalian target of rapamycin (mTOR) cascade, which involves 
epileptogenesis, suggesting that IGF-1 is involved in the downstream regulation of 
neuronal behavior after traumatic brain injury (TBI). In our experiment, the role of IGF-1 
in epileptogenesis in an organotypic hippocampal culture (OHC) model of posttraumatic 
epilepsy is investigated. Lactate production, lactate dehydrogenase (LDH), electrical 
activity, and phosphorylation of Akt, MAPK, and S6 proteins were measured and their 
corresponding inhibitors are applied to investigate epileptogenesis. Results show that 
short-term application of IGF-1 result in a decreased risk of epileptogenesis while chronic 
application leads to an increase in ictal activities. In addition, chronic IGF-1 application 
promotes the activation of the Akt-mTOR signaling cascade, but not the MAPK signaling 
cascade.  
 2 
 
The second project uses small interfering RNA (siRNA) silencing to inhibit the epileptic 
pathway. In neurons, actin binding proteins (ABP) and tubulin binding proteins 
contribute to axon projection. Expression of these proteins is directly associated with the 
growth of neural circuits. Since epilepsy is deemed to be caused by the formation of 
abnormal neural circuits, logically speaking, if these proteins are appropriately silenced, 
epileptogenesis should be inhibited. In this research, cofilin, as an important ABP, is 
proposed as a targeted protein to control the growth of axons in order to understand the 
relationship between axon growth and epilepsy at a neuron level.  
 
The third project is to evaluate seizure-induced neural injury using optical coherence 
microscopy. Since this technology can image living tissue based on an intrinsic scattering 
index, it can be used to investigate neural activities before and after epilepsy and monitor 
the development of seizure activities at a tissue level. In this project, we firstly validate 
neuron imaging by OCM with confocal imaging, demonstrating that OCM can be applied 
to the study of neuron death in the OHC model. Then, after integrating the OCM system 
with a perfusion system, we use this system to study neural activities and show that there 
are different optical signals from neurons and surrounding neuropil. 
  
The remaining parts of the thesis include other projects done in collaboration with Dr. 
Liu’s and Dr. Haas’s laboratories. 
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1. Introduction 
 
1.1 Background 
 
Curing brain disease has always been one of the ultimate goals of medical research. 
Doctors and patients from different eras and cultures have kept working together to heal 
brain disease not just because it significantly reduces the quality of life of patients and 
their families, but also because it is usually deadly. Nowadays, brain diseases are mainly 
divided into two categories: congenital diseases [1] and acquired diseases [2]. Among 
these brain diseases, epilepsy attracts more attention because the mechanism of 
epileptogenesis is still elusive [3, 4]. In 2013, 22 million people around the world were 
suffering from epilepsy and 80% of them were from developing countries. In addition, 
soldiers with head trauma are at greater risk of acquiring epilepsy than civilians with head 
trauma by a factor of 560:29. 70% of patients can control their epilepsy by continual 
medication. However, the remaining 30% need to undergo surgery due to drug resistance. 
Once epilepsy occurs, patients suffer severe seizures along with a large amount of neuron 
death due to excitotoxicity. Epilepsy is not curable and the mechanism of epileptogenesis 
is still elusive. Therefore, in order to control the development of epilepsy, investigation 
into the mechanism of epilepsy is needed. 
 
There are many hypotheses about the mechanism of epilepsy. The abnormal formation of 
neural circuits after physical injury is one of them [5, 6]. In addition, the imbalance of 
calcium concentration in neurons [7, 8] and gene mutation [9, 10] are also widely 
proposed to explain epileptogenesis. Usually, there are three main pathways for seizure 
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propagation in partial seizures and primary generalized seizures: 1) partial seizure; 2) 
secondary generalization and 3) primary generalized seizure. In order to increase the 
efficiency of the management of epilepsy, many methods have been proposed and 
developed. Anticonvulsant drugs are used to control epilepsy at early stage [11]. 
According to specific types of epilepsy, the patient’s condition, and the effects of drugs, 
initially a single medicine is proposed to control epilepsy. With the development of the 
epilepsy and the failure to control it with only one drug, another medicine will be added. 
There are several kinds of medicine available for this purpose, including phenytoin, 
carbamazepine and valproate [12-14]. Beside these traditional methods, many research 
groups have implemented advanced technologies to control epilepsy. Rogawski [15] 
applied convection-enhanced delivery for antiepileptic drugs delivered to the brain. He 
demonstrated that convection-enhanced delivery is able to restrict seizures and can 
replace orally-administered antiepileptic drugs due to its excellent efficiency. Martin, et 
al. [16] developed a ketogenic diet as an established non-pharmacological treatment for 
controlling seizures in patients with drug resistant epilepsy. This ketogenic diet with high 
fat and low protein forces the body to use ketone bodies as the predominant fuel to reduce 
seizures. Beside drug delivery for controlling epilepsy, deep brain stimulation method is 
also widely investigated. Hamania, et al. [17] investigated the electrical stimulation of the 
anterior nucleus of the thalamus of rats because stimulation of this area is effective in 
controlling the occurrence of epileptic seizures. Fisher, et al. [18] further applied deep 
brain stimulation to patients with epilepsy. They designed a multicenter, double-blind, 
randomized trial of bilateral stimulation of the anterior nuclei of the thalamus for 
localization-related epilepsy. Furthermore, gene therapy is also widely used in the 
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treatment of epilepsy. McCown [19] investigated adeno-associated virus (AAV) vectors 
research in epilepsy treatment. Due to AAV vectors possessing the capability of long 
term and nontoxic gene expression in the central nervous system, they have great 
potential for the treatment of intractable temporal lobe epilepsy. Liu, et al. [20] provided 
micro RNA based therapy. These miRNAs, as regulators in seizure-induced cell death, 
can potentially be used to treat epilepsy. Although in current medication epilepsy is still 
not curable, more and more attention will be paid to the disease. It is believed that in the 
near future, there will be huge progress in the treatment of epilepsy. 
 
1.2 Motivation 
 
IGF-1 is released in brain tissue after head injury. The elevation of its level and an 
increase in the phosphorylation of IGF-1 receptor (IGF-1R) indicate that IGF-1 is 
involved in modulating neuronal behavior after traumatic brain injury (TBI) [21, 22]. 
Research reveals that IGF-1 contributes to neurite development and axon projection by 
activation of the MAPK (ERK) and the PI3K-Akt signaling cascades through the 
phosphorylation of IGF-1 receptor. Actually, these two molecular cascades further lead to 
the activation of mTOR cascade, which has a strong relationship with epileptogenesis in 
much published work [23-25]. In animal models of hypoxic-ischemic and traumatic brain 
injury, IGF-1 is neuroprotective [22], and these results establish IGF-1 regulation as a 
potential treatment for head injury. However, long-term application of IGF-1 involves an 
increased risk of epileptogenesis because the downstream regulation of the 
phosphorylation of IGF-1R can cause the activation of mTOR cascade. In addition, there 
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are many efficient experimental methods to investigate the role of IGF-1 in 
epileptogenesis. We investigated the role of IGF-1 in epileptogenesis in an organotypic 
hippocampal culture (OHC) model of posttraumatic epilepsy. We  applied IGF-1 during 
the latent period between trauma and the appearance of spontaneous seizures, and 
measure lactate production (the biomarker of increased seizure activity), lactate 
dehydrogenase (LDH, the biomarker of increased cell death), electrical activity, and the 
phosphorylation of Akt, MAPK, and S6 (the marker of mTOR activation) proteins. We 
also applied IGF-1 together with inhibitors of Akt, MAPK and mTOR and measured 
lactate and LDH levels to investigate how IGF-1 regulates epileptogenesis at a 
biomolecular level. Hence, IGF-1 regulation in neural activities after brain injury 
provides a novel direction to study the mechanism of epileptogenesis at a biomolecular 
level. 
 
After TBI, at a neuron level, expression or overexpression of some actin and its related 
proteins contributes to the formation of abnormal neural circuits by promoting axon 
sprouting [5]. The driving force behind axon outgrowth is generated by ATP-dependent 
modification of the actin and microtubule cytoskeletons. The actin cytoskeleton regulates 
changes in lamellipodial and filopodial shape for directed growth, while the microtubule 
cytoskeleton is responsible for the elongation of the axon itself. Many actin-binding 
proteins (ABPs) and tubulin-binding proteins (TBPs) involve dynamic polymerization 
and depolymerization of actin and tubulin. If these ABPs and TBPs are appropriately 
silenced or reduced by RNA interference technology, epileptogenesis will be inhibited. In 
this research, cofilin is the first targeted protein. Cofilin targeted siRNA (cfl1-siRNA) is 
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applied to OHC models. We measured axon length and density outside brain slices and 
collect LDH and Lactate data to determine whether cofilin driven axon growth is 
associated with epileptogenesis at a neuron level.  
 
To investigate epileptogenesis at a tissue level, optical coherence microscopy (OCM) as 
an emerging optical technology provides an ideal image modality to study neural 
activities. OCM images living tissue based on an imaged tissue intrinsic scattering index 
without labeling [26], and it is very sensitive to the change of the refractive index inside 
the neurons. During neuron activity, the refractive index of neurons is changed due to the 
change of membrane potentials, indicating that OCM can be used to investigate the 
propagation of neural activities before and after epilepsy and can monitor the 
development of seizure activities at a tissue level. In addition, by using OCM, real time 
3D images of living cultures can be constructed at a fast speed compared to traditional 
confocal imaging, increasing the efficiency of the brain slice image investigation. 
 
It is very beneficial to apply engineering technology to the study of biology. In this work, 
electrophysiological recording, western blots, siRNA and OCM technology are combined 
to study the mechanism of epileptogenesis at biomolecular, neuron and tissue levels, 
through electrical, chemical, biological and optical methods. This integration not only 
provides efficient tools for the investigation of unknown mechanisms of epilepsy, but 
also exhibits the potentialities of cooperation between different disciplines.   
 
 8 
1.3 Thesis outline 
 
My current research for my Ph.D. dissertation focuses mainly on three categories of 
epilepsy study: 1) the regulation of insulin-like growth factors (IGFs) in epileptogenesis 
at a biomolecular level (Chapter 2); 2) the use of siRNA silencing to inhibit epilepsy at a 
neuron level (Chapter 3); and 3) the application of optical coherence microscopy (OCM) 
in the investigation of epilepsy at a tissue level (Chapter 4). In addition, some other 
smaller experiments done during the Ph.D. study are also summarized in Chapter 5. 
There follows an overall conclusion in Chapter 6. 
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2. Spontaneous Ictal Activities Induced by IGF-1 Signaling 
Cascade 
 
 2.1 Background 
 
Epilepsy is defined as the unprovoked occurrence of seizures. This brain disease is 
usually onset after traumatic brain injury (TBI) [27]. A soldier with severe head injury 
has an increasing risk of 560-fold [28], compared to civilians with severe head injury 
with the risk of 29-fold [29], to develop epilepsy in their later life. Among the whole 
population, 1-3% suffer epilepsy each year [30, 31]. Continuous seizing with high 
frequency, or epilepsy, can lead to the death of neurons after excitotoxicity [32] and 
threaten the lives of patients [31]. 70% of these patients use antiepileptic drugs to control 
their epilepsy because epilepsy is incurable with current medications; while the 
remaining 30% of patients obtain surgery due to drug resistance [33-35]. Efficient 
treatment for epilepsy remains elusive as the mechanisms of epileptogenesis remain 
unknown. 
 
Epilepsy which threatens brain health of around 1% population can be induced by TBI, 
and its origin, or epileptogenesis, usually occurs in the latent period between injury and 
appearance of spontaneous seizures [36, 37]. Before the latent period, initial brain injury 
causes death of some neurons; during latent period, little neuronal death is observed. 
After the latent period, large amount of neurons are lost along with the occurrence of 
observed spontaneous epilepsy by electrophysiological recording in an OHC model [38, 
39]. In order to prevent neuron death caused by epilepsy, specific protein inhibitors can 
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be used to block involved molecular signaling cascade key points to inhibit the formation 
of epileptic circuits. Among these molecular events targets, that mammalian target of 
rapamycin (mTOR) is activated after brain injury has attracted large amounts of attention. 
Relevant research indicates that inhibition of mTOR can curb the abnormal formation of 
neural circuit reorganization [40]. Mutations in genes that regulate mTOR are associated 
with epilepsy-link focal malformations of cortical development including tuberous 
sclerosis complex [41-43]. Seizures generated in an animal model of tuberous sclerosis 
complex, a genetic disorder in which mTOR is constitutively active, were suppressed by 
mTOR inhibitor rapamycin [44, 45]. 
 
Given the facts that mTOR cascade is a downstream activation of Mitogen-activated 
protein kinase (MAPK)/ extracellular signal-regulated kinases 1/2 (ERK1/2) and 
phosphatidylinositol 3-kinase (PI3K) signaling cascades, which are activated [46-48] by 
the phosphorylation of insulin-like growth factors-1 (IGF-1) and its receptor (IGF-1R) 
binding, it is very interesting to investigate the relationship between concentration of 
IGF-1 in the brain and epileptogenesis through mTOR cascade. IGF-1 plays a major role 
in cells development, from glucose metabolism [49], protein synthesis and growth [50], 
to cell proliferation [51], cell cycle [52], survival [53], apoptosis [54], and differentiation 
[55]. They belong to a complex biological signaling system for intracellular and 
extracellular communication. This complex system, or the IGF “axis”, contains two cell-
surface receptors (IGF1R and IGF2R), two ligands (insulin-like growth factor 1 (IGF-1) 
and insulin-like growth factor 2(IGF-2)), a family of six high-affinity IGF-binding 
proteins (IGFBP-1 to IGFBP-6), and associated IGFBP degrading enzymes [56, 57]. In 
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particular, IGF-1 is a single chain polypeptide of 70 amino acid residues cross-lined by 
three disulfide bridges with molecular weight of ~7.6 kDa. It has insulin-like effects, 
including stimulation of glucose consumption in adipose tissue, and performs homology 
to proinsulin [6]. In addition, IGF-I can control cell proliferation and differentiation by 
regulating specific events in the G1 phase of the animal cell cycle [58], especially in 
neurogenesis [59]. As a matter of fact, many research works demonstrate that IGF-1 is 
neuroprotective when it is applied to animal models of hypoxic-ischemic and traumatic 
brain injuries [22, 23], and these make exogenous IGF-1 application as a potential 
medication control for chronical treatment of brain injuries. Since brain injury is 
associated with changes in IGF-1 signaling and one of the downstream effectors of IGF-1 
signaling, mTOR pathway, is involved in epileptogenesis, hypothesis that 
phosphorylation of IGF-1R may contribute to epileptogenesis through its activating 
molecular signaling cascade is proposed to explain epileptogenesis. If prolonged 
application of IGF-1 is demonstrated in promotion of seizures in the long run, 
suppression of some key notes in IGF-1 activated molecular cascades will provide an 
efficient way to inhibit the formation of abnormal neural circuits, turning out to be a 
promising treatment for epilepsy. 
 
In this experiment, organotypic hippocampus culture models are used to mimic the 
compressed scale of clinical epileptogenesis. Metabolism products are collected to verify 
the living conditions of neurons under spontaneous epilepsy and electrophysiology is 
used to confirm neural activities in different conditions. 
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2.2 Materials and Methods 
 
2.2.1 Preparation for organotypic hippocampal slice culture 
 
In organotypic hippocampal slice culture (OHC), life cycle and physical development of 
neurons can be investigated in a compressed timeline [60]. Epileptogenesis, for instance, 
fully develops in an OHC model [61]. Latent period starts from 3 days in vitro (DIV) and 
spontaneous seizure emerges around 7 DIV. Since the timeline is short in OHC models 
compared to in vivo experiments, fast experimental throughput of drugs screen for 
molecular mechanisms can be obtained efficiently in several weeks’ cycles.  
 
Hippocampal slices with a thickness of 350 µm were dissected from the hippocampus of 
7 day old Sprague-Dawley rats. After dissection, all slices were maintained from 0 DIV 
with nutrition medium which includes Neurobasal-A, GlutaMax (0.5 mM), Gentamicin 
(30 µg/ml), IGF-1/insulin, sodium selenite (Se) (14 ng/ml) and bovine serum albumin 
(BSA) (250 µg/ml) (All from Life Technologies). These slices were stored in an 
incubator with humidified 5% CO2 at a temperature of 37 
oC. Different testing 
components were added into the culture medium from DIV 3 for specific experimental 
purposes. For IGF-1 dilution, IGF-1 was added into the medium on 0 DIV just after 
dissection. On DIV 3, three kinds of concentrations of IGF-1 and vehicle solution (-IGF) 
were added, and the cultures were maintained to DIV 14. For the molecular cascade 
experiments, IGF-1 was also added into the medium on 0 DIV after dissection, and then 
on DIV 3, Akti1/2 (the inhibitor of Akt), FR180204 (the inhibitor of MAPK) and 
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rapamycin (the inhibitor of mTOR) were added into the medium and the cultures were 
maintained to DIV 14. In phenytoin experiments, IGF-1 was added into the medium for 
the first 3 days, and then phenytoin was added into the experimental cultures. All samples 
were maintained to DIV 14.  For electrophysiological recordings, all slices were treated 
with IGF-1 on 0 DIV. From DIV 3, IGF-1 and vehicle solution were added into the 
culture medium to create +IGF-1 groups and control groups. After DIV 10, slices from 
the +IGF-1 groups and the control groups were processed electrophysiological recording 
in a recording chamber. As to acute IGF-1 response recording, all slices were cultured in 
the +IGF-1 media from DIV 0 then in the –IGF media from DIV 3. These slices were 
transferred to a perfusion system for acute exposure to IGF-1 and neural activity signals 
were collected. All animal use protocols were approved by the Institution Animal Care 
and Use Committee at Lehigh University and were conducted in accordance with the 
United States Public Health Service Police on Humane Care and Use of Laboratory 
Animals. 
 
2.2.2 IGF-1 dilution study  
 
IGF dilution experiment investigated the relationship between concentration of IGF-1 and 
seizure activity. From 3 DIV, the concentrations added into medium of three groups out 
of four groups were 1.52 ng/L (0.2 nM), 15.2 ng/L (2 nM) and 152 ng/L (20 nM), 
respectively, while another group was used as a control group and only vehicle solution 
(nutrition media without IGF) was added. These concentrations of IGF-1 were added bi-
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weekly into the media to maintain cultures. Culture medium for lactate dehydrogenase 
(LDH) and Lactate tests was collected on DIV 7, 10 and 14, respectively. 
 
2.2.3 IGF-1 activation molecular cascade study 
 
Epileptic pathway study is to understand how and when IGF-1 regulated seizure activity 
by its activating molecular cascades, especially in our experiment by the PI3K-Akt 
cascade and the MAPK (ERK1/2) cascade after epileptogenesis period. On DIV 0, four 
groups were treated with the +IGF-1 medium. From DIV 3, different components were 
added into these four groups bi-weekly: Group A with +IGF-1 +DMSO (Dimethyl 
sulfoxide), Group B with -IGF +DMSO, Group C with +IGF-1 +Akti1/2 and Group D 
with +IGF-1 +FR180204. The culture medium for LDH and Lactate test was collected on 
DIV 7, 10 and 14, respectively. In order to understand if the two cascades were regulated 
parallel by the phosphorylation of IGF-1R, we mixed Akti1/2 and FR180204 in one 
following experimental group. The experiment was redesigned: Group A with +IGF-1 
+DMSO (Dimethyl sulfoxide), Group B with -IGF +DMSO, Group C with +IGF-1 
+Akti1/2 and Group D with +IGF-1 +Akt1/2 and + FR180204.  
 
In addition, we further tested mTOR as a downstream product of these two molecular 
cascades by using rapamycin. On DIV 0, three groups were all treated with the +IGF-1 
medium. From DIV 3, rapamycin was added into an experimental group, and the 
experiment was designed as follows: Group A with +IGF-1 +DMSO; Group B with –IGF 
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+DMSO and Group C with +IGF-1 +rapamycin. The culture medium for LDH and 
Lactate test was collected on DIV 7, 10 and 14. 
 
2.2.4 Phenytoin testing experiment 
 
Phenytoin, as an anticonvulsant drug, is widely used to manage seizures. In this 
experiment, phenytoin was used to suppress ictal activities induced by long term 
exposure to IGF-1. This demonstrated that neuron death after the latent period in the 
OHC model was caused by seizures. The experiment was set as follows: Group A with 
+IGF-1 +DMSO, Group B with –IGF +DMSO, and Group C with +IGF-1 +phenytoin. 
The culture medium for LDH and Lactate test was collected on DIV 7, 10 and 14. 
 
2.2.5 LDH and lactate tests for IGF-1 regulation cascades study 
 
Lactate dehydrogenase (LDH) and lactate tests were used to evaluate cell death and 
seizure activity. When cell death occurs, LDH is released from the cells and hence LDH 
is used as a cell death indicator. Lactate is used as an ictal activity indicator as a cell 
metabolism product. When neurons are experiencing ictal activity, due to high level of 
anaerobic activities, lactate is released from cells. LDH and Lactate concentrations were 
measured in the collected culture medium with the kits from Roche and Eton, 
respectively. In addition, LDH concentration was calculated in terms of arbitrary units 
(au), while lactate concentrations were calculated through known lactate standards with 
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the units of mM. All LDH and lactate value were calculated into values of each day and 
normalized.  
 
2.2.6 Electrophysiological recordings of long/short term exposure to IGF-1  
 
Local field potential (LFP) is recorded in the electrophysiological recording by placing 
small electrodes (TM33A05, World Precision Instruments, USA) into brain slices. Many 
neural activities, including synaptic activities, fast action potentials, calcium spikes, 
intrinsic currents, and gap junctions, contribute to LFPs, and therefore it is very efficient 
and reliable to investigate neuronal activities by LFPs recordings [62]. 
 
 
 
Figure 1 The illustration of the recording system for long term exposure to IGF-1 study. Slices are placed in 
the middle of the recording chamber with constant humidity (95%) and temperature (37 oC). Neuronal 
activity is recorded by two electrodes from CA1 and CA3. Signals are collected by amplifier and processed 
by computational algorithm. 
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In this experiment, for chronic IGF-1 application study, between DIV 11 and 14, 31 
slices treated with +IGF-1 and 32 slices treated with –IGF from 3 DIV were placed on a 
humidified platform for extracellular electrophysiological recording, or LFP recordings, 
as shown in Figure 1. Two tungsten electrodes were used to record electrical activity in 
the slices with amplification of 1000x for a minimum of 1 hour. Data was digitized by 
using OpenEx software and processed by designed MATLAB algorithm. In algorithm, a 
threshold of 100 to 200 µV amplitude was used to select ictal activities, and paroxysmal 
ictal activities lasting more than 10 seconds, with inter-event interval of less than 0.5 
seconds, were classified as electrographic seizures (ictal events). 
 
 
 
 
Figure 2 The illustration of recording system for acute exposure to IGF-1 study. Slices are placed in the 
perfusion chamber with constant temperature (35 oC). Oxygenated artificial cerebrospinal fluid (ACSF) is 
continually flowed into the chamber. An electrode is used to collected neuronal activity from the CA1 
neurons. All data are collected by an amplifier and processed by a written algorithm.  
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For acute IGF-1 experiment, electrical recording system is integrated into a perfusion 
system, as shown in Figure 2. Compared to chronic IGF-1 electrical recording with two 
electrodes on CA1 and CA3 of brain slices, separately, only one electrode was placed on 
the CA1 region of brain slices. The recording data was collected and analyzed by a 
written LabVIEW program. The same criteria for determining neuronal activities as ictal 
activities were used in analysis. 
 
2.2.7 Seizure raster plotting 
 
All collected data were rectified. A threshold of 100 to 200 µV was used to select ictal 
activities from normal activities. The rectified data were binned into binary data, with bin 
duration of 0.5 seconds. If there was an event above the threshold, the binary value in this 
bin duration was marked as 1 (an active bin), otherwise as 0. Then a period of the 
window duration of 10 seconds was used to plot ictal activities. There are 20 bins (0.5 s) 
in the window duration (10 s). We calculated an event rate by the number of positive bins 
with values of 1 dividing the number of total bins. We set the threshold as 0.9 (18 bins 
with values of 1 in the window duration) for the event rates and event rates above this 
threshold would be considered ictal events (seizures) and plotted in red in the raster plot 
figure. Finally, the event rates were plotted to quantify each ictal activity in the recording. 
In addition, an ictal event counting program was also used to calculate the numbers of 
ictal events in one hour recording and the total ictal duration per hour.  
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2.2.8 Western blots for IGF-1 regulation cascade study 
 
Western blots, as a routine technology for protein analysis, are implemented to 
investigate the cascades activated by binding of IGF-1 and its receptor [63]. Brain slices 
were harvested on an experimental DIV after 2x fresh nutrient medium washing. Samples 
were transferred to lysis buffer, which contained phenylmethanesulfonyl fluoride (PMSF) 
stock, radioimmunoprecipitation assay (RIPA) buffer, protease inhibitors, 
ethylenediaminetetraacetic acid (EDTA) and phosphatase inhibitors. This lysis buffer was 
used to lyse brain slices and extract proteins. 10-20% Tris-Glycine polyacrylamide gels 
were used to load proteins after BCA test and these proteins were separated by gel 
electrophoresis. After overnight transferred under 25 V, proteins in the gel were fully 
collected on polyvinylidene fluoride (PVDF) membranes. These membranes were stained 
with targeted primary antibodies cocktail, such as 1:500 anti-phospho-IGF-1R 
(Y1135/1136), 1:1000 anti-IGF-1R, 1:10000 anti-phospho-Akt (S473), 1:10000 anti-
phospho-MAPK (T202/Y204), 1:10000 anti-phospho-S6 (S235/236), 1:10000 anti-Akt, 
1:10000 anti-MAPK and 1:10000 anti-S6 in blocking buffer. After overnight incubation 
at 4 oC, a secondary antibody, anti-rabbit IgG, was applied for one hour. After washing 
away extra antibody and enhanced chemiluminescence (ECL) treatment, the stained 
membranes were imaged on a two channel infrared scanner and the bands were 
quantified with the imageJ software.  
 
2.2.9 Perfusion system 
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Perfusion system allowed us to apply known testing components on experimental brain 
slices, as shown in Figure 2. In this experiment, all brain slices were treated with the 
+IGF-1 medium from DIV 0 to DIV3 and with the vehicle medium treated only from 
DIV 3 to DIV 12 or 13. On the day of recordings, brain slices were transferred to a 
conventional submerging chamber and continuously superfused with oxygenated 
artificial cerebrospinal fluid (ACSF, 95% O2 and 5% CO2) at 37 
oC with a flow rate of 60 
ml/h, as shown in Figure 2. ACSF contained the following compounds: 25 mM NaHCO3, 
3.5 mM KCl, 1.3 mM MgCl2, 2 mM CaCl2, 11 mM D-glucose and 126 mM NaCl. A 
tungsten microelectrode with impedance of 0.5 MΩ was placed on a CA1 region of a 
brain slice to record neuronal activities. The recorded signals were amplified by 1000x 
and processed by LabVIEW software. ACSF with the vehicle component (–IGF ACSF) 
was initially flowed into the chamber for 35 min, and then the +IGF-1 ACSF was flowed 
for 1 hour. Finally, the –IGF ACSF was reflowed for another one hour. After recording, 
digital signals would be analyzed by a designed MATLAB algorithm.    
 
2.3 Preliminary Results 
 
2.3.1 IGF-1 dilution experimental results 
 
Figure 3a shows that ictal activity increases with the increasing +IGF-1 concentration. On 
DIV 7, greater neuronal activities in the +IGF-1 Group D with the highest +IGF-1 
concentration were observed compared to the other lower +IGF-1 concentration groups 
and the control group. However, higher concentration of +IGF-1 also implied that more 
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molecular signaling cascades were activated by the phosphorylation of +IGF-1R. More 
mTOR cascades were activated and therefore more seizure activities would be induced. 
As shown in Figure 3b, on DIV 7, there is no significant difference among LDH values of 
all experimental groups. This could be explained that in latent period (from DIV3 to 
DIV7) IGF-1 played a role in neuron protection. However, the +IGF-1 group with highest 
concentration had highest neuronal death compared to the –IGF, 0.01×IGF and 0.1×IGF 
groups on DIV 10 (p < 0.001, p < 0.001, and p < 0.001, respectively, each group n=6), 
and 14 (p < 0.001, p < 0.001, and p = 0.002, respectively, each group n=6). This 
confirmed that the concentration of +IGF-1 we used could lead to obvious neurons death 
in the long term experiment while for short term application it was neuroprotective. 
Based on these two results, we concluded that there might be association between ictal 
activities and neuron death according to the convergence of the LDH and Lactate results. 
In addition, this experiment shows that in the OHC model, behaviors of neurons are very 
sensitive to the concentration of IGF-1. One way ANOVA with Holm-Sidak post-hoc 
method is used for statistic analysis and the –IGF group is used as the control group. 
(***p<0.001, **p<0.01 and *p<0.05) 
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Figure 3 Plot of Lactate and LDH for IGF dilution experiment. (a) LDH data of IGF Dilution (from DIV 7 
to DIV 14). (b) Lactate data of IGF Dilution (from DIV 7 to DIV 14). One way ANOVA with Holm-Sidak 
post-hoc method is used for statistic analysis and +IGF group is used as the comparing group. (***p<0.001, 
**p<0.01 and *p<0.05)  
 
 
 
2.3.2 Short term IGF-1 neuroprotection immediately after injury  
 
Having obtained the best concentration of IGF-1 applied in the media, IGF-1 short term 
neuroprotective function was investigated by comparing neuron numbers of IGF-1 treated 
brain slices and control groups in vitro on DIV 3. From DIV 0, brain slices were treated 
with the +IGF-1 solution with the concentration of 152 ng/L and the vehicle solution, 
separately. On DIV 3, all brain slices were fixed and stained by anti-NeuN (1:100; 
Monoclonal antibody; Millipore; NeuN is a neuron-specific nuclear protein) for confocal 
images as shown in Figure 4a and b. Numbers of neurons from the +IGF-1 groups and 
the control groups were compared and the quantified results are shown in Figure 4c, 
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suggesting that neurons at the CA1 and CA3c regions of +IGF-1 treated brain slices 
maintained a significantly higher survival rate than those in the control groups. However, 
neurons at the CA3b region showed almost the same survival rate in both conditions. In 
addition, in Figure 4d, LDH results revealed that the +IGF-1 group had less neuron death 
(p < 0.001, n = 6 cultures). It is concluded from these data that IGF-1 promote increased 
survival rate immediately after brain injury, and this result is accorded with other former 
work [22, 23]. 
 
2.3.3 Long-term exposure to IGF-1 increasing risks of epilepsy 
 
Given the fact that short term application IGF-1 promotes neuron survive after injury, it 
is very rational to investigate how neurons respond to long-term exposure to IGF-1 after 
injury. Neuron counts of two experimental groups of prolonged treatment with the +IGF-
1 and the vehicle application were compared. The vehicle groups without continual IGF-
1 treatment were set as the control groups. As shown from Figure 5a, both experimental 
groups were treated 20 mM of +IGF-1 from DIV 0. On DIV 3, compared to the control 
groups without further +IGF-1 treatment, experimental +IGF-1 groups were continually 
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maintained in the +IGF-1 media to the harvesting date (on 25 DIVs). On DIV 25, we 
 
Figure 4 IGF-1 is neuroprotective immediately after injury. (a) Representative micrographs of neurons in 
the CA3c region of the organotypic hippocampal cultures at DIV 3 (anti-NeuN stained). The culture at left 
image had been treated with the IGF-1 between DIV 0 and 3, while the culture at right image had been 
treated with the vehicle. (b) Quantification of survival neurons in the CA3c, CA3b, and CA1 regions at 
DIV 3 in the cultures maintained in medium with IGF-1 or vehicle. (c) LDH released into culture medium 
between DIV 0 and 3. Data are represented as mean ±SEM. * represents p < 0.05, *** p < 0.001 versus 
control (vehicle). 
 
fixed and stained all samples. Figure 5c and d were representative micrographs of the 
brain slices with/- long term exposure to IGF-1. From these micrographs, increased 
neuron death is observed in the long term IGF-1 treated groups. In Figure 5b, counting 
results showed that neurons at CA1 and CA3c of the –IGF treated brain slices maintained 
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a significantly higher survival rate than those in the +IGF-1 groups. Neurons at CA3b, 
like those in short term neuroprotective experiment, showed almost the same survival rate 
in both conditions.  
 
Figure 5 Prolonged, late IGF-1 treatment leads to decreased neuron survival rate. (a) Experimental design. 
(b) Neuron counts in the organotypic cultures on DIV 25 (+/– IGF-1 protocol as in (a)). (c) Representative 
micrographs of anti-NeuN staining in CA3c layer of the brain slices after long term exposure to IGF-1 on 
DIV 25. (d) Representative micrographs of anti-NeuN staining in CA3c layer of the brain slices without 
long term exposure to IGF-1 on DIV 25. Data are represented as mean ± SEM. * p < 0.05, *** p < 0.001. 
 
In Figure 6a and b, LDH results further confirmed that the +IGF-1 group had more 
neuron death from DIV 10 to 14, while lactate results, on the other hand, showed more 
neural activities in the +IGF-1 group than those in the control group from DIV 7 (p = 
0.017, 0.017 and 0.01, respectively, n = 6 cultures). 
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Figure 6 Prolonged, late IGF-1 treatment leads to increased ictal activity and cell death. (a) Lactate (the 
marker of ictal activity) and, (b) LDH (the marker of cell death) released into the culture medium by IGF-1 
treated (+IGF-1) and the vehicle-treated (–IGF-1) cultures versus time in culture, suggesting that long term 
exposure to IGF-1 leads to the increased of neuron death and severe neuronal activity. 
 
In order to further demonstrate that there were more ictal activities in the prolonged 
+IGF-1 group, electrophysiological recording was used to investigate +IGF-1 long term 
impacts on brain slices. There were the two experimental conditions designed: +IGF-1 
long term treated groups and vehicle (–IGF) control groups. Both of these groups were 
treated by +IGF-1 from DIV 0 to avoid neuron death caused by injury and maintain high 
survival rate of neurons. After DIV 3, 31 slices were continually treated with the +IGF-1 
solution, while 32 slices were treated with the vehicle solution. On DIV 12 and 13, these 
brain slices were transferred to a recording chamber with suitable humidity and stable 
temperature of 37 oC. Two electrodes were placed on the CA1 and CA3 regions of the 
brain slices to collect local field potential signals, as shown in Figure 1, and the total 
recording time was 1 hr. 
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Figure 7 Electrical recordings and data analysis obtained from long term IGF-1 treatment brain slices leads 
to increased ictal activity. (a) Representative recordings of electrographic seizures in organotypic cultures 
exposed to (right) long term +IGF-1 treatment or not (left) on DIV 11-14. Seizure detail is shown in 
expanded time scale recordings in the bottom row. (b) Quantification of seizure frequency, duration, and 
time seizing per hour, indicating that long term IGF-1 treatment significantly increase the intensity of 
seizure activity. Data are represented as mean ± SEM. * p < 0.05. 
 
TDT amplifier and OpenEx software were used to digitize and record signals. Only 
samples with ictal activities were analyzed based on the definition of epilepsy, which is 
that under a given threshold (100 to 200 µV in this experiment) ictal event lasts 10 
seconds and the interval is less than 0.5 seconds. The quantification, as shown in Figure 
7a, indicated that the duration of epilepsy induced in the +IGF-1 groups was different 
from that induced in the –IGF groups. 21 out of 31 +IGF groups showed seizure 
activities, while 19 out of 32 –IGF groups showed seizure activities. Further statistical 
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analysis, as shown in Figure 7b, presented that seizure duration of +IGF-1 treated slices 
was longer than that of –IGF treated slices with a significant difference (p = 0.012, n = 21 
+IGF-1 cultures, and n = 19 –IGF cultures). By combining the results obtained from 
number of seizures and average seizure duration, this experiment demonstrates that 
+IGF-1 regulates seizure activities after latent period. In addition, more ictal activities 
induced by +IGF-1 have longer seizing time than those spontaneous ictal activities 
induced in the vehicle treated samples.  
 
2.3.4 Temporal effects of IGF-1 applied to samples  
 
In order to fully understand how IGF-1 regulates neural behaviors after application, it is 
very necessary to investigate timing effect of IGF-1. It is known that phosphorylation of 
IGF-1 receptor leads to the activation of PI3K and MAPK signaling cascade, but the 
question on when IGF-1 initiates these cascades remains unclear. By investigating 
phosphorylation of +IGF-1R through western blotting, we can depict a clear signaling 
passway to render the timing effects of IGF-1. Our western blot result shows that 
phosphorylation of IGF-1 receptor starts at around 30 mins after treatment, as shown in 
Figure 8a. Timing results of phosphorylation of IGF-IR with time points of 15, 30, 60, 
120 and 240 mins were developed after exposure. Phosphorylation rate of IGF-1R with 
different time points was calculated and the resulted shows significant difference between 
15 and 30 mins, *p < 0.05, as shown in Figure 8b. This indicates that activation of the 
cascades starts at around 30 mins after IGF-1 treatment. 
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Figure 8 Western Blot results of timing of IGF-1R phosphorylation. (a) Timing of phosphorylation of IGF-
IR with time points of 15, 30, 60 120 and 240 mins. (b) Phosphorylation rate of IGF-1R with different time 
points. Phosphorylation rate shows significant difference between 15 and 30 mins, *p < 0.05. 
 
2.3.5 Short term exposure to IGF-1 showing no effects on seizure  
 
Having demonstrated that long term exposure to IGF-1 leads to increased risks of seizure, 
whether short term exposure to IGF-1 has effect on seizure becomes a crucial experiment 
to fully understand how IGF-1 regulates ictal activities.14 slices were treated by the 
+IGF-1 medium from DIV 0 to DIV 3. From DIV 3, the vehicle solution was applied to 
treat slices. On DIV 11 to 14, these slices were transferred to the perfusion system for 
IGF-1 acute treatment study. An electrode was placed on the CA1 region of the brain 
slices to collect neuronal activities and the analog signals were processed to digital 
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signals by LabVIEW. Brain slices were submerged into the –IGF ACSF for 35 mins at 
the beginning. ACSF with +IGF-1, following former 35 mins –IGF ACSF flowing, 
flowed into the recording chamber for 1 hour (from 2100 s to 5700 s), and then the –IGF 
ACSF was switched back to the recording chamber for another 1 hour recording (from 
5700 s to the end), as shown in Figure 9a. Seizure activities were analyzed before, during 
and after 1 hr +IGF-1 treatment, as shown in Figure 9b. The amount of time seizing per 
hour was not significantly different before, during, or after acute IGF-1 application 
(paried t-test, –IGF-1 to +IGF-1, p = 0.582; +IGF-1 to –IGF-1, p = 0.368, n=14 cultures). 
Number of seizures per hour was also not significantly different before, during, or after 
acute IGF-1 application (paired t-test, –IGF-1 to +IGF-1, p = 0.806; +IGF-1 to –IGF-1, p 
= 0.541, n = 14 cultures). The analysis starting time was set as 30 min or 15 min before 
the treatment condition change due to the incubation time of IGF-1 phosphorylation 
(details of analysis not shown). These results showed that IGF-1 had few effects on 
seizure activities in short term treatment, and hence it can be concluded that prolonged 
IGF treatment will cause epileptic actvities and neuron death in brain slices rather than 
acute IGF-1 application. Interestingly, it was recently reported that acute application of 
IGF-1 enhances chemically induced seizures [64], in contrast to our finding that acute 
application of IGF-1 has no effect. This difference is likely due to different mechanisms 
of IGF-1 effect on seizures induced by chemoconvulsants versus spontaneously occuring 
seizures in our model. 
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Figure 9 Acute IGF-1 has no obvious influence on neural seizure activities. (a) Full time recording of acute 
IGF-1 experiment: –IGF ACSF flowed at the beginning for 35 mins; +IGF ACSF flowed successively after 
–IGF treatment from 2100 s to 5700 s; from 5700 s to the end, –IGF ACSF flowed again into the recording 
chamber. (b) Quantification of time seizing per hour prior, during and after +IGF-1application. Data are 
represented as mean ± SEM. 
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2.3.6 Akt and S6, but not MAPK signaling, activated by long-term IGF-1 treatment, 
and increased protein synthesis 
 
Western blotting was used to investigate how IGF-1R phosphorylation regulates PI3K 
and MAPK signaling cascades. 12 slices from 4 animals were treated by the +IGF-1 
medium from DIV 0 to DIV 3. After DIV 3, slices were maintained in the presence or 
absence of IGF-1 until DIV 6. During this latent period, few neurons die during 
epileptogenesis. This period separates the effects of phosphorylation of IGF-1R and the 
following potential changes in intercellular signalling which suggests that effects of 
phosphorylation of IGF-1 recpetors signaling cascades can be fully investigated while 
effects of neuron death caused by epilepsy have been minimized. The phosphorylation of 
Akt at Thr 308 and Ser 473, MAPK at Thr 202/Tyr 204, and S6 at Ser 235/236 and Ser 
240/244, as shown in Figure 10a. These results revealed that long-term exposure to IGF-1 
significantly increased phosphorylation of Akt at Thr 308 (p = 0.029),  Ser 473 (p < 
0.001),  S6 at Ser 235/236 (p = 0.036) and Ser 240/244 (p = 0.009). However, 
phosphorylation of MAPK was not affected significantly by prolonged IGF-1 (p = 
0.256). In addition, as shown in Figure 10b, an 18 ± 5 % increase in the amount of 
protein contained in the cultures indicated that prolonged IGF-1 exposure increased 
protein systhesis (p = 0.002, n = 12 cultures). This work was contributed by Lauren 
Boller, Katherin Walters and Corrina Lucini. 
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Figure 10 Prolonged, late IGF-1 activates Akt-mTOR, but not MAPK signaling. (a) Quantification of band 
densities. Density of phosphorylated protein bands was divided by respective cultures were used 
normalization. (b) Comparison of total (all) protein detected in single culture lysates reveals that IGF-1 
treated cultures have higher protein content than vehicle treated cultures. This work was contributed by 
Lauren Boller, Katherin Walters and Corrina Lucini. Data are represented as mean ± SEM. * p < 0.05, ** p 
< 0.01, *** p < 0.001. 
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2.3.7 Further investigation the relationship between IGF-1 activated PI3K and MAPK 
cascades and mTOR cascade 
 
There are two main signaling cascades activated by the phosphorylation of +IGF-1: the 
PI3K-Akt signaling cascade and the MAPK/ERK signaling cascade. In order to 
determine which signaling cascade is dominated in activation of seizure activities in long 
term exposure, we used two inhibitors to block the key points of the signaling cascades: 
Akti1/2, inhibitor of Akt, and FR180204, inhibitor of ERK. The concentration of Akti1/2 
and MAPK were 1 µM and 10 µM, respectively. In this experiment, we had four 
experimental groups (each group n = 6 cultures): Group A of +IGF-1 +DMSO, Group B 
of –IGF +DMSO, Group C of +IGF-1 +Akti1/2, and Group D of +IGF-1 +FR180204. 
Among these groups, Group A with +IGF-1 +DMSO was a control group. In Figure 11a, 
both the –IGF group and the +Akti 1/2 group show obvious decreases in ictal activities 
compared with that of the +IGF-1 group and the +FR180204 group on DIV 6, 10, and 14 
(ANOVA p < 0.001 for all days, post-hoc Bonferroni p = 0.007, 0.011, 0.012 
respectively). This indicates that due to the inhibition of the Akt node in the cascade, less 
epilepsy occurs with the inhibition of the signaling cascade of PI3K-Akt-mTOR. In 
addition, our LDH data shows that on DIV14 both the –IGF group and the Akti group 
have less neurons death compared to the +IGF-1 group (ANOVA p < 0.001, post-hoc 
Bonferroni p = 0.003), while the MAPK inhibitor (FR180204) group does not have 
significant effects compared to the +IGF-1 groups, as shown in Figure 11b. One way 
ANOVA with Holm-Sidak method is used for statistic analysis and +IGF group is used 
as the control group. (***p<0.001, **p<0.01 and *p<0.05). 
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Figure 11 Plot of LDH and Lactate for IGF activated the PI3K-Akt-mTOR and the MAPK signaling 
cascades (C and D groups were added Akti and FR180204, respectively). (a) LDH data of IGF activated the 
PI3K-Akt-mTOR and the MAPK signaling cascades (from DIV 7 to DIV 14). (b) Lactate data of IGF 
activated PI3K-Akt-mTOR and MAPK signaling cascades (from DIV 7 to DIV 14). (One way ANOVA 
with Holm-Sidak method, ***p<0.001,**p<0.01 and *p<0.05) 
 
Although the MAPK inhibition was not statistically significant, we noticed that LDH 
levels were somewhat lower in the FR 180204 treated +IGF-1 cultures, compared to 
vehicle treated +IGF-1 cultures on DIV 10 and 14. We hypothesized that inhibition of 
Akt and MAPK signaling may have synergistic neuroprotective effects in IGF-1 treated 
cultures. In order to further confirm the relationship between the PI3K-Akt signaling 
cascade and the epileptogenesis, we modified the experiment above. The same conditions 
were applied in Group A, B and C, but a combination of Akti1/2 and FR18204 with 
concentrations of 1 µM and 10 µM was applied to Group D. Lactate testing results 
showed that more neural activities were present in +IGF-1 group compared to other 
groups from DIV7 to DIV14, as shown in  
Figure 12a. Due to the inhibition of Akti1/2, neural activities were reduced in Group C 
and D. LDH testing showed that from DIV10 more neuron death occur in the +IGF-1 
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group. Less neuron death in Group C and Group D was attributed to the inhibition of 
Akti1/2, as shown in  
Figure 12b. These results can be used to conclude that compared with the MAPK 
(ERK1/2) cascade, the PI3K-Akt cascade plays an important role in epileptogenesis. In 
addition, the inhibition of Akt node can reduce neural activities and decrease neuron 
death. Therefore, the Akt node is a promising target point in epilepsy treatment in the 
future. 
 
 
 
Figure 12 Plot of LDH and Lactate for IGF activated the PI3K-Akt-mTOR and the MAPK signaling 
cascades (C and D groups were added Akti and Akti+FR180204, respectively). (a) LDH data of IGF-1 
activated the PI3K-Akt-mTOR and the MAPK signaling cascades (from DIV 7 to DIV 14). (b) Lactate data 
of IGF-1 activated the PI3K-Akt-mTOR and the MAPK signaling cascades (from DIV 7 to DIV 14). (One 
way ANOVA with Holm-Sidak method, ***p<0.001, **p<0.01 and *p<0.05) 
 
We then investigated if rapamycin, an inhibitor of mTOR (downstream of the Akt 
cascade), affected IGF-1 contribution to epileptogenesis. Three groups of experimental 
conditions were tested, including Group A +IGF-1 +DMSO, Group B –IGF +DMSO, and 
Group C +IGF +Rapamycin. On DIV 0, all groups were treated +IGF-1 only. On DIV 3 
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slices were maintained in the presence or absence of IGF-1, as well as rapamycin. Sample 
media was collected on DIV 6, 10 and 14, followed by LDH and Lactate tests, as shown 
in Figure 13a and b. Lactate shows that higher concentration of lactate was obtained from 
Group A, suggesting that rapamycin had reduced neural activities significantly (ANOVA 
p = 0.015, 0.02, < 0.001 on DIV 6, 10, and 14, respectively, with post-hoc p = 0.014, 
0.002, and 0.001, n= 6 cultures per condition). In addition, LDH showed that on DIV 14, 
higher neuron death occurred in Group A compared to the rapamycin treated group and 
the vehicle group, suggesting that application of rapamycin had reduced neuron death 
caused by ictal activities. (ANOVA p < 0.001, post-hoc p < 0.001, n = 6 cultures per 
condition) 
 
 
 
Figure 13 Effect of rapamycin (RAPA) applied starting from DIV 3 on epileptogenesis. Rapamycin was 
applied to +IGF-1 cultures starting from DIV 3, and significantly reduced lactate (a) and LDH (b). Data are 
represented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
 
 
 38 
2.3.8 Anticonvulsant phenytoin suppressed IGF-1 induced increases in ictal activity 
and cell death 
 
Anticonvulsant Phenytoin (100 µM), as an anti-epileptic drug, was used to demonstrate 
that neuron death in our experiment was related to ictal activities. In the OHC model, 
while the first wave of neuron death occurs due to injury, the second wave of neuron 
death is caused by ictal activities. Three groups of experimental conditions were tested: 
Group A +IGF +DMSO, Group B –IGF +DMSO, and Group C +IGF +Phenytoin. On 
DIV 0, all groups were treated with +IGF-1 only. On DIV 3 slices were maintained in the 
presence or absence of IGF-1, as well as phenytoin. Sample media was collected on DIV 
6, 10 and 14, followed by LDH and Lactate tests, as shown in Figure 14a and b. Lactate 
showed that higher concentration of lactate was obtained from Group A, suggesting that 
phenytoin had reduced ictal activities significantly (ANOVA p = 0.011 for DIV 7, and p 
< 0.001 for DIV 10 and 14, with post-hoc Bonferroni p = 0.01, < 0.001, < 0.001 between 
+IGF-1 and +IGF-1 +phenytoin groups on DIV 7, 10, and 14, respectively, n= 6 cultures 
per condition). In addition, LDH showed that on DIV 7 and 14, higher neuron death 
occurred in Group A compared to the phenytoin treated group and the vehicle group, 
suggesting that application of phenytoin had reduced neuron death caused by ictal 
activities. (ANOVA p < 0.001, p = 0.003, and post-hoc Bonferroni p < 0.001, p = 0.003, 
n = 6 cultures per condition.) 
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Figure 14 Effect of anticonvulsant phenytoin was applied starting from DIV 3 on epileptogenesis. 
Phenytoin was added to +IGF-1 cultures starting from DIV 3, and significantly reduced lactate (a) and 
LDH (b). Data are represented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
2.4 Summary of chapter 2 
 
In this project, we first determined the optimal concentration of IGF-1 for our 
experiments is 152 ng/L (20 nM). Following the short term IGF-1 neuroprotection 
evaluation experiments from DIV 0 to DIV 3, the long term exposure to IGF-1 was 
investigated by neuron survival rate, electrophysiological recording, LDH test, and 
Lactate test. These results concluded that prolonged IGF-1 application lead to increased 
ictal activities. In addition, the temporal effects of IGF-1 regulation in neuron signaling 
cascades, especially the PI3K-Akt-mTOR cascade, starts at around 30 mins after IGF-1 
treatment. This timing effect allowed the study of how IGF-1 regulates signaling cascade 
in acute application. The results showed that acute application of IGF-1 has no effects in 
epileptogenesis. Furthermore, the signaling cascades activated by the phosphorylation of 
IGF-1 receptor were studied by western blotting. The signaling cascade of PI3K-Akt-
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mTOR has been demonstrated to play an important role in epileptogenesis, and increased 
protein synthesis rate was also discovered in the +IGF-1 treated groups. In all, this series 
of experiments concluded that the short term application of IGF-1 just after injury 
promote neuron survival while the long term application of IGF-1 leads to severe ictal 
activities and neuron death by activating the PI3K-Akt-mTOR cascade.  
 
2.5 Future work 
 
Binding of IGF-1 and IGF-1R will activate the PI3K-Akt-mTOR signaling cascade. 
However, there are many kinds of receptor tyrosine kinases (RTKs) on the surface of cell 
membrane. Whether these RTKs yet contribute to epileptogenesis is still a hot debate. In 
addition, mTOR is not only activated by the PI3K-Akt-mTOR signaling cascade while 
many other molecular signaling cascades can also activate mTOR cascade. In future, 
potential targeted RTKs, as well as upstream activators of mTOR, can be investigated to 
fully understand epileptogenesis and provide potential targeted drugs for epilepsy 
treatment. 
 
Since in vitro OHC model showed that long term exposure to IGF-1 contributed to 
epileptogenesis, this experiment can be implemented in vivo for further study. 
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3. Using Small interfering RNA (siRNA) silencing to inhibit 
epileptic pathway  
 
3.1 Background 
 
Neurons belong to a family of polarized epithelial cells. This polarization allows neurites 
to grow into dendrites or axons when there are stimuli in the cytoplasm and/or 
extracellular matrix, leading to the formation of neural circuits. In order to guide axons to 
other neurons and to form neural circuits, many relevant proteins and molecules 
including actin-binding proteins (ABPs), tubulin-binding proteins (TBPs), extracellular 
matrix cell adhesion molecules and chemoattractive/chemorepulsive molecules are 
involved [65-67]. The initial step in the formation of neural circuits is axon sprouting, 
which is driven by growth cone motility. The driving force to move the axon is generated 
by ATP-dependent modification of the actin and the microtubule cytoskeletons. The actin 
cytoskeleton regulates changes in lamellipodial and filopodial shape for directed growth, 
while the microtubule cytoskeleton is responsible for the elongation of the axon itself. 
 
Many ABPs and TBPs are involved in the dynamic polymerization and depolymerization 
of actin and tubulin. Among these molecules, ABPs attract more attention because they 
are specifically found in increasing number at the growing edges of neurites [68], 
contributing to the projection of axons. Hayashi and Shirao determined that 
overexpression of drebrin, an actin-binding protein, will change the shape of dendrites 
sprouting for migration [69]. In addition, their research further confirmed that drebrin E 
is involved in the regulation of axonal growth through actin-mysoin interactions [70]. 
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Additionally, Twinfilin-2 and girdin have been shown to be involved in neurite 
outgrowth [71, 72]. Another ABP protein, the WASP-family verprolin homologous 
(WAVE1) protein, as well as the actin-related protein (Arp)-2/3 complex, is observed to 
take part in regulation of axon growth [73-75]. In addition, Profilin 2, only expressed in 
brain tissue, is also a potential ABP study target due to its contribution to synaptic 
plasticity and neurite growth [75]. By studying these proteins, we will better understand 
the mechanisms underlying neurite growth and the formation of neural circuits, as well as 
the shed light on the occurrence and development of brain diseases based on alterations in 
neurite growth and circuit formation. For example, after traumatic brain injury (TBI), 
many axons are cut or damaged, and therefore, new axons will grow to reconstruct neural 
circuits. However, some axon growth results in abnormal formation of neural circuits, 
creating a potential for the development of epilepsy in the future. It is known that altered 
regulation of neurite growth proteins, including ABPs and TBPs, are also associated with 
seizure activities. Indeed, increasing level of Acidic calponin, as well as Drebrin A, are 
observed [76, 77] during epileptogenesis.   If these ABPs and TBPs are appropriately 
silenced or reduced, epileptogenesis also may be inhibited due to the blocking of the 
formation of abnormal neural circuits. However, inhibitors of these proteins are not 
readily available. In order to silence each potential protein efficiently, gene knock-down 
technologies are an ideal tool. Small interfering RNA (siRNA) technology is usually used 
as a RNA interference tool to silent targeted protein expression by inducing short term 
silencing of protein coding genes. siRNA is usually a 20 to 25 base pair double-strand 
RNA with two phosphorylated 5’ ends and two hydroxylated 3’ ends with two 
overhanging nucleotide. Once it is transferred into cells, the antisense strand of the 
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transferred siRNA will link an RNA-induced Silencing Complex (RISC) to the targeted 
mRNA. mRNA is cleaved by RISC and hence no protein will be synthesized. In order to 
investigate how targeted neurite growth works during epileptogenesis, target specific 
siRNA are applied to targeted neurons. There are many ways to deliver siRNA into a 
neuron, including electroporation, nucleofection, calcium-phosphate co-precipitation, 
lipofection, adenoviruses, lentiviral vectors, microinjection, and biolistics [78]. However, 
some of these methods are time consuming and expensive, while others have low 
transfection efficiencies. In addition, neurons are difficult to transfect. Hence, the GE 
Lifesciences Dharmacon Accell siRNA were used for efficient transfection without the 
use of additional reagents, viruses, or instruments [79, 80].  
 
Here, we describe the use of a modified organotypic hippocampal culture (OHC) model, 
optimized for the integration of siRNA technology to investigate epilepsy. Usually, 300 
to 400 µm thick [81] hippocampus slices are utilized in OHCs; however, this thickness 
limits siRNA delivery to several superficial neuron layers and prevents siRNA uptake in 
neural layers below surface neural layer. In our adaptation of the OHC model, 
hippocampal brain slices were cut to be 200 to 300 µm thick in order to increase siRNA 
uptake efficiency,  
 
In this experiment, we firstly investigate cofilin, which is a potentially important ABP in 
epileptogenesis study, since it has been shown to contribute to the outgrowth of neurites. 
It suggests there is a strong association between cofilin regulation and axon sprouting 
after TBI. We hypothesized that during epileptogenesis, if expression of cofilin is silent, 
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few abnormal neural circuits will be formed due to less axon sprouting, although a direct 
relationship between cofilin concentration and epileptogenesis remains elusive. To 
address this issue, we used cfl1-siRNA to mute expression of cofilin after dissection, and 
then compared fluorescent images, LDH and Lactate results obtained from both of cfl1-
siRNA treated groups and control groups. 
 
 3.2 Materials and methods 
 
3.2.1 Organotypic hippocampal brain slices prepared 
 
Hippocampal slices with a thickness of 250 µm were dissected from the hippocampus of 
7 days old Sprague-Dawley rats. After dissection, all slices were maintained from 0 DIV 
with nutrition medium which includes Neurobasal-A, GlutaMax (0.5 mM), Gentamicin 
(30 µg/ml), insulin (175 mg/L), sodium selenite (Se) (14 ng/ml) and bovine serum 
albumin (BSA) (250 µg/ml) (all from Life Technologies). Slices were maintained in an 
incubator with humidified 5% CO2 and temperature of 37 
oC. Cultures received a bi-
weekly media change. During media changing, phase contrast microscopy was used to 
observe axon sprouting and slice qualities. All animal use protocols were approved by the 
Institution Animal Care and Use Committee at Lehigh University and were conducted in 
accordance with the United States Public Health Service Police on Humane Care and Use 
of Laboratory Animals. 
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3.2.2 siRNA transfection 
 
Dharmacon Accell Green Non-targeting Control siRNA (GE Lifesciences) was used to 
investigate optimal hippocampal slice thickness. According to Dharmacon’s suggested 
protocol, the siRNA mix was applied to cultures one day post-dissection (DIV 1). On 
DIV 4, the slices were assessed with fluorescent microscopy to determine the amount of 
Accell siRNA uptake. Once the optimal slice thickness was identified, non-targeting 
siRNA (GE Lifesciences Dharmacon Accell) was applied to slices in accordance with the 
previously mentioned protocol. To maintain long-term gene silencing, the Accell siRNA 
mix was replaced with growth factor-supplemented medium on DIV 4. The cultures 
received bi-weekly media changes: the first was a reapplication of Accell siRNA mix and 
the second was growth factor-supplemented medium. Protein knockdown was visualized 
after DIV 5 (96 hours after Accell siRNA application). 
 
Cfl1-siRNA was also applied to slices to silence cofilin expression one day after 
dissection. In this experiment, two groups were treated with cfl1-siRNA on DIV 0 and 
one of these two groups was further treated with cfl1-siRNA on DIV 7 (the other group is 
only treated on DIV 0). The control group was treated with non-targeting siRNA.   
 
3.2.3 Immunohistochemistry 
 
In this experiment, immunostaining was used to study the efficiency of cfl1-siRNA in 
cofilin silencing. On DIV 6, organotypic hippocampal cultures were washed twice with 
phosphate buffered saline (PBS), followed by immediate fixation with 4% 
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paraformaldehyde in PBS. After a two-hour fixation, cultures were washed with PBS, 
permeabilized in 0.3% Triton X-100 in PBS, and blocked with 10% goat serum in PBS. 
Cultures were then incubated overnight at 4°C with Alexa Fluor 555 labeled-anti-NeuN 
antibody (1:100; Monoclonal antibody; Millipore; NeuN is a neuron-specific nuclear 
protein).  For the cofilin knock-down experiment, cultures were incubated overnight at 
4°C with anti-cofilin antibody (1:10,000; Monoclonal antibody; Cellsignal) and anti- β-
tubulin (1:500; Mouse monoclonal [2G10] to beta III Tubulin; Abcam). After overnight 
incubation, secondary antibodies (1:10,000 Alexa Fluor 568 goat anti-rabbit IgG, Eugene, 
for anti-cofilin; 1:200 Alexa Fluor 488 goat anti-mouse IgG2a, Abcam, for β-tubulin) 
were applied to the slices.  Following all antibody incubations, cultures were washed with 
PBS and mounted for imaging. Images were taken with a fluorescent microscope at 4x 
and 20x objectives. 
 
3.2.4 LDH and Lactate testing for siRNA silencing experiment 
 
Lactate dehydrogenase (LDH) and lactate test were used to evaluate cell death and 
seizure activity, respectively. Culture media were collected at each media change, when 
fresh culture media were added to cultures. LDH and Lactate concentrations were 
measured as described earlier. 
 
3.2.5 The efficiency of cfl1-siRNA in knock-down cofilin expression demonstrated by 
western blotting 
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Western blots allowed us to investigate siRNA silencing timing in the OHC model. Brain 
slices were harvested on DIV14, and western blotting was carried out as described 
earlier.  Antibody cocktail of anti-cofilin (1:10,000) and anti-GSK-3β (1:10,000) was 
used.  
 
 
 
Figure 15 250 µm thick brain were cultured from DIV 3 to DIV 14. Even on DIV 14, neurons layers at DG, 
CA3 and CA1 regions are preserved, n = 3, suggesting these slices were qualified for siRNA uptake. The 
scale bar is 800 µm. 
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3.3 Preliminary Data 
 
3.3.1 Brain slices with optimized thickness for siRNA uptake 
 
 
 
Figure 16 Confocal microscopy confirmed presence of neurons and siRNA uptake capability in 250 µm 
hippocampal slices. Composite images of 250 µm slices at 35x. (a) Stained red with anti-NeuN; (b) Accell 
Green Non-targeting Control siRNA; (c) stained with anti-NeuN and control siRNA. (d) A composite 
image at 35x displaying the CA1 neuronal layer at the bottom of a 250 µm slice stained with anti-NeuN 
and control siRNA. The scale bar is 800 µm. This work was contributed by Anna Sternburg. 
  
From DIV 0, 250 µm thick brain slices were cultured in the same manner as 350 µm 
thick brain slices in the traditional OHC model. As shown in Figure 15, neuron layers of 
DG, CA3 and CA1 were preserved in these 250 µm thick brain slices. In addition, we 
used confocal imaging to confirm siRNA uptake of 250 µm thick brain slices, as shown 
in Figure 16 (This work was contributed by Anna Sternburg). We stained brain slices 
with anti-NeuN, first, (red in Figure 16a), and then with Accell Green Non-targeting 
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Control siRNA (green in Figure 16b). The two images were merged, as shown in Figure 
16c and in Figure 16d with 35x microscopy.  
 
Although siRNA was successfully delivered to neurons, neurons stained by anti-NeuN 
were not matched with neurons stained by Accell Green Non-targeting Control siRNA as 
shown in Figure 16d. Further investigation of confocal images indicated that neurons 
stained by anti-NeuN were mainly located in the middle of the brain slice, while those 
stained by siRNA were distributed on the surface layers. Anti-NeuN is supposed to stain 
all types of neurons, including pyramidal neurons, interneurons and granule neurons. 
However, the siRNA stained cells do not belong to any type of these neurons. Whole-cell 
recordings carried out in Prof. Haas’s laboratory revealed that cells with the presence of 
green fluorescent non-targeting siRNA were not electrically excitable.  A raised 
hypothesis suggests that siRNA stained neurons are damaged neurons after brain injury. 
Further careful evaluation of the image in Figure 16d indicates that there may be weak 
green color in these red dots, suggesting that living neurons might be matched in Figure 
16d. It may be that the brightness of Figure 16b was not enough to render the existence of 
living neurons treated with non-targeting siRNA. Although this experiment demonstrates 
that 250 µm can intake non-targeting siRNA, we still need straight forward experimental 
results to convince the efficiency of siRNA application in 250 µm slices.  
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3.3.2 Cofilin silencing 
 
Cofilin, belonging to a family of ABPs, involves in the dynamics of polymerization and 
depolymerization of F-actin. It first achieves a cut of a targeted F-actin by binding to an 
actin monomer located in the polymer and then changes the actin 
monomer’s conformation while remaining bound to the newly generated (+) end [82]. If 
cofilin-targeted siRNA (cfl1-siRNA) is applied in the OHC model, formation of axon 
sprouting should be inhibited, hence reducing the possibility of formation of abnormal 
neural circuits.  
 
 
Figure 17 Western Blot results of the comparison of the control groups and the siRNA treated groups. (a) 
Exposure images of total cofilin in the control group A and C and the siRNA treated group B (treated on 
DIV 0 only) and D (treated on DIV 0 and 7). (b) Statistic Analysis of intensity of cofilin exposure, n = 3, 
***p<0.001. 
 
Western blot results were processed and analyzed by the ImageJ, as shown in Figure 17a 
and b. Compared to control Group A and C without cfl1-siRNA treatment, Group B and 
D were treated by cfl1-siRNA treatment on DIV 0 and/or DIV 7, respectively. Exposure 
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results showed that there was an obvious decreasing amount of cofilin expression, as 
shown in Figure 17a. In addition, Intensity of western blotting of Group B treated on DIV 
0 only was significantly higher than that of Group D treated on both DIV 0 and DIV 13, 
as shown in Figure 17b. This result was used to confirm that cfl1-siRNA could be used as 
a cofilin gene knocking down tool to investigate epileptic pathway by muting cofilin 
expressing RNA. In addition, this experiment further convinces that siRNA works very 
well in 250 µm brain slices. 
 
 
 
Figure 18 Immunostaining images of neurons by cofilin and β-tubulin stain. (a) Immunostaining images of 
neurons by cofilin stain. (b) Immunostaining images of neurons by β-tubulin stain. (c) Merged images of 
(a) and (b). The scale bar is 50 µm. 
 
However, whether cfl1-siRNA is only targeting cofilin gene is not clear in our 
experiment. In other to answer this question, we processed immunostaining into 
experiments. Firstly, we applied both β-tubulin and cofilin primary antibodies into brain 
slices to figure out what kinds of cells in the brain slices express cofilin. As shown in 
Figure 18a, compared to β-tubulin which was only expressed in neurons in Figure 18b, 
cofilin was also expressed in axons generated from the brain slices (Figure 18c).  
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Figure 19 Comparison of intensity of axon images in the control groups, the non-targeting siRNA treated 
groups and the cf1l-siRNA treated groups, respectively. (a) Axon images in the control groups. (b) Axon 
images in the non-targeting siRNA treated groups, and (c) axon images in the cfl1-siRNA treated groups. 
(d) Quantification and comparison of image intensities in outside brain slices axons, cells, CA3, CA1 and 
DG, respectively. Data are represented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. The scale 
bar is 50 µm, 
 
If we inhibited cofilin expression in axons, we could potentially constrain the growth of 
axons, and therefore the abnormal formation of neural circuits was managed. In order to 
reach this experimental goal, we carried out an experiment to show how cfl1-siRNA 
regulates the growth of axons surrounding the brain slices. In the experiment, non-
targeting siRNA and cfl1-siRNA were applied into brain slice cultures from DIV 0, 
respectively. On DIV 7, all conditions treated slices were fixed, and processed 
immunostaining. Figure 19a, b and c show the staining images of axons in the control 
groups, the non-targeting siRNA treated groups and the cfl1-siRNA treated groups, 
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respectively. Compared to images intensity of control and non-targeting groups, image 
intensity of cfl1-siRNA treated groups significantly decreased, as shown in Figure 19d. 
This indicates that cfl1-siRNA knocks down cofilin in axons, not just in cell bodies, and 
hence can be used as a tool to specifically investigate axons sprouting outside brain 
slices. 
 
 
Figure 20 Effects of cfl1-RNA applied from DIV 3 on axon growth. (a) Axon length calculated on DIV 7 
from the non-targeting siRNA control groups, and (b) axon length was calculated on DIV 7 from the cfl1-
siRNA treated groups. Comparison of (c) axon length and (d) density of axons from both the control groups 
and the cfl1-RNA treated groups. (e) Lactate (the marker of ictal activity) and (f) LDH (the marker of cell 
death) released into the medium with no significant difference in comparison of the non-targeting siRNA 
control groups and the cfl1-RNA treated groups. 
 
Figure 20a and b shows that axon length was calculated on DIV 7 from the non-targeting 
siRNA control group and the cfl1-siRNA group. The contour of these brain slices was 
600 pixels (um), and axons crossing points on these contours were also calculated to 
measure the density of axons outside brain slices. Statistical analysis (paired t-test, non-
targeting siRNA to cfl1-siRNA, p = 0.96 for axon length and p = 0.16 for crossing points, 
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n = 3 cultures), as shown in Figure 20c and d, indicates that cfl1-siRNA did not greatly 
reduced the length of axons and the density of axons outside brain slices, comparing to 
that in the control groups. Followed LDH and Lactate data showed that axon growth 
inhibited by cfl1-siRNA outside the brain slices was not associated with epileptogenesis, 
as shown in Figure 20e and f, suggesting that cofilin might not involve in abnormal 
formation of neural circuits, or other proteins replaced the role of cofilin in regulation of 
axon growth when cofilin was absent. Hence, in order to conform the role of cofilin in 
epileptogenesis, more experiments pertain to cofilin associated inner brain slices axon 
growth are required to be implemented.    
 
3.4 Summary of Chapter 3 
 
250 µm thick brain slices uptake siRNA and allow for long-term culture study. In 
addition, cofilin, which is related axon growth, was successfully targeted by specific cfl1-
siRNA. Reduced expression of cofilin is further verified by the western blots results in 
the OHC model. However, axon length and density of axons around brains slices are not 
significantly different in the cfl1-siRNA treated groups and the non-targeting siRNA 
treated control groups.  Lactate and LDH results of two experimental groups further 
suggest that the connection between cofilin and epileptogenesis is weak. According to 
these results, other actin binding proteins may replace cofilin when cofilin was knocked 
down in the experiment. In order to further confirm the relationship between cofilin 
expression and epileptogenesis, optogenetics technology is encouraged to be applied into 
the investigation of axons growth of cfl1-siRNA treated brain slices.  
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3.5 Future work 
 
Besides cofilin, other proteins belong to the family of ABPs, such as gelsolin, thymosin, 
profilin, CapZ, are going to be systematically tested by siRNA tool, due to their potential 
possibility contribution to axon sprouting. In addition, tubulin-binding proteins (TBPs) 
also play an important role in axon sprouting by consolidating the direction of movement 
of neurite growth cone, and hence TBPs like tau proteins, dynein and kinesin can be also 
systematically tested by targeted siRNA. LDH, Lactate and electrophysiological 
recording will be applied to investigate neural death, activities and seizures. Several 
proposed proteins will be selected out as potential antiepileptic drugs targets.  
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4. Electrical recording system integrated with OCM technology 
(this work was done in collaboration with Dr. Chao Zhou and 
Fengqiang Li) 
 
4.1 Background 
 
Optical coherence tomography (OCT) is developed in early 1990s for cross-sectional 
imaging in biological systems without invasive approaches [83]. At beginning, this 
technology was very similar to ultrasonic pulse-echo imaging because it implemented 
low-coherence interferometry to generate a two-dimensional image of optical scattering 
from internal tissue microstructures. Several years later, in order to enhance imaging 
capability of confocal microscopy in highly scattering media, OCT technology with low 
coherence interferometry had been combined with confocal microscopy and this 
combination emerged optical coherence microscopy (OCM) [84]. In recent years, this 
powerful optical imaging has been widely applied for various biomedical imaging due to 
its obvious advantages such as noninvasive imaging, fast speed and 3D imaging 
construction. According to current research reports, OCM has been successfully applied 
in neuronal architecture researches and many brain disease studies, including brain tumor 
[85, 86], Parkinson’s disease [87, 88], and Alzheimer’s disease [89, 90]. However, only a 
few reports focus on application of OCM in epilepsy study. Eberle, et al. used OCT to 
detect changes in optical properties of cortical tissue in vivo in mice before and during the 
induction of generalized seizure activity [91]. Li, et al. successfully implemented OCM to 
investigate neuron death in an OHC model [92]. OCM technology has been reported to 
be sensitive to scattering change in excited neurons. Lazebnik, et al. [93] implemented 
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functional OCT to investigate neural activity by scattering changes. They stimulated 
abdominal ganglion of Aplysia californica to induce neuron activities. Increasing 
scattering changes was observed clearly in firing neurons after stimulation, and the 
presence of continual increasing scattering signals was captured by the OCT system. 
Therefore, advanced OCM technology renders a greatly potential application in epilepsy 
study. 
   
Our preliminary data showed that neuron death was associated with the occurrence of 
seizures in OHC model. However, we want to monitor neuronal activities during 
seizures. That means we intended to obtain optical images during electrical recording.  
Considering that the OCM system with the capability of real-time imaging without 
injuring biological samples, we will integrate OCM system and perfusion chamber for 
further epilepsy study. In this project, we firstly validated OCM images neuron counting 
by confocal imaging. Neuron death was also observed by OCM system. Then we tested 
TTX acute impacts on neuronal activities by adding them into ACSF solution in the 
recording chamber. In addition, we used our integrated system to study OCM intensities 
of neurons and neuropil during stimulation recording. These experiments confirm our 
integrated system is qualified in neuronal activities study.  
 
4.2 Materials and methods 
 
4.2.1 Organotypic hippocampal culture preparation for cell counting and ictal study 
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Hippocampal slices with a thickness of 350 µm were dissected and maintained as 
described earlier.  
 
4.2.2 Ultrahigh-Resolution OCM 
 
In this experiment, all the brain slices were imaged by an ultrahigh-resolution OCM 
system with a supercontinuum light source (SC-400-4, Fianium Ltd., Southampton, 
United Kingdom). This light source, especially, with a center wavelength of 800 nm and 
bandwidth of 220 nm, can provide an axial resolution with around 1.5 µm in the brain 
slices. In order to further extend the depth of focus to 200 µm, and obtain a transverse 
resolution with the values of 2.3 µm at focus, 2.5 µm at 40 µm, and 3.1 µm at 90 µm 
above or below the focus with a 10x Olympus objective, a 175-deg conical lens [90, 94] 
was constructively used in the sample arm. As a result, the sensitivity of the OCM system 
was greatly increased to 90 dB with 3 mW power at a 20,000 A-scan/s image speed. 
Before imaging, the organotypic hippocampal culture was transferred to a 35 mm Petri 
dish with a thin bottom of 200 µm above an inverted objective from culture wells, and 
kept into media at room temperature. In order to maintain the same measurement 
conditions, the focus of the OCM was set consistently 100 µm above the bottom surfaces 
of all hippocampal slices and an imaging range of 1.8 × 2.1 mm2 was implemented to 
cover the entire brain slice with 800 × 800 axial scans per volume. A 3-D OCM data set 
was obtained in 40 s. With the purpose of reducing speckle noise and improving the 
signal-to-noise ratio of the OCM images, six repeated scans (n = 6) were performed for 
each brain slice and averaged. This work was collaborated with Fengqiang Li. 
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In the following experiments, this OCM system was integrated with a perfusion system 
for long-term brain slice imaging. Brain slices were transferred to a conventional 
submerged chamber and continuously superfused with oxygenated artificial cerebrospinal 
fluid (ACSF, 95% O2 and 5% CO2) at 37 
oC and a flow rate of 60 ml/h. ACSF contained 
the following compounds: 25 mM NaHCO3, 3.5 mM KCl, 1.3 mM MgCl2, 2 mM CaCl2, 
11 mM D-glucose and 126 mM NaCl. A tungsten microelectrode with impedance of 0.5 
MΩ was placed on the CA1 region of the brain slice to record neuronal activities. The 
recorded signals were amplified by 1000x and processed by LabVIEW software.  
 
In addition, the OCM system is updated to a space-division multiplexing optical 
coherence tomography (SDM-OCT) technology system with <3 µm spatial resolution 
and an imaging speed of 3.2 M A-scans/s. 16 parallel cross-sectional OCT channels are 
used to image different neural groups simultaneously with ≤1 ms temporal resolution, 
and make it possible to record nanometer level membrane displacement associated with 
neuron action potentials with high signal-to-noise ratio (>10x). 
 
4.2.3 Confocal Imaging for the whole brain slices 
 
For the validation experiments, organotypic hippocampal cultures were fixed 
immediately after OCM imaging with a mixture of 4% paraformaldehyde in phosphate 
buffered saline (PBS). After two-hour fixation, the cultures were washed with PBS, 
permeabilized in a mixture of 0.3% Triton X-100 in PBS, and blocked with 10% goat 
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serum in PBS. Cultures were then incubated with anti-NeuN antibody (NeuN is a neuron-
specific nuclear protein) conjugated with Alexa Fluor 555 overnight at 4°C.  Following 
antibody incubation, the cultures were washed and mounted for imaging. 
 
A laser scanning confocal microscope (Zeiss LSM 510 META, Germany) was used to 
image samples by a 5x and a 40x objective lens, respectively. 5x objective was used for 
sample localization while 40x for imaging. Cultures were all lightened from the same 
side with the confocal microscope in order to keep consistence along with that in the 
OCM imaging. The excitation wavelength of the confocal microscope was 543 nm. With 
the using of 40x objective and setting the interval in the z-direction as 1 µm, each 3D 
confocal stack (318 µm × 318 µm × 80 µm) was obtained in 270 s. Forty-two 3D 
confocal stacks were acquired with about 10% overlaps for each individual image 
between stacks in order to cover the entire culture (2.0 mm × 2.7 mm × 80 µm). A 
stitching program based on Fiji, an extension of ImageJ, was applied to stitch individual 
3D confocal stacks into a completed 3D image set of an entire brain slice. 
 
4.2.4 Cell counting based on the confocal imaging 
 
Algorithm counting based on MATLAB was fully developed to cell counting of whole 
slices. Firstly, a masked image with only the hyposcattering regions was created by using 
an intensity threshold. Then, a template image showing a dark circular region within a 
white background was moved across the same en face OCM image to calculate 
correlation coefficient values for all the pixels. In order to match the size of the neuron 
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and achieve the highest correlation coefficients, an optimal combination of the thresholds 
for the template size (L = 15 µm) and the radius of the circle (R = 6 µm) was determined. 
Once we set up the parameter for the sizes of neurons, a second masked image was 
generated showing only regions with correlation coefficient values above a threshold. 
Combination of these two masked images generated a mask highlighting regions with 
both low intensity and high correlation coefficients from the en face OCM image by 
using a third threshold. Next, all the masks from different depths were integrated to form 
the 3-D stack. Watershed algorithm was used to separate and identify individual neurons 
in the volume [95, 96]. A 3-D size filter was then applied to get rid of objects identified 
by the watershed algorithm that were two small or too large for a neuron. Finally, in order 
to facilitate visualization of the identified cells for comparison of neurons in the confocal 
image, the cells identified by the algorithm were marked on en face and 3-D OCM 
images as red dots/spheres, The number of cells, or red dots in in 3-D image stacks, was 
then automatically counted. This work was done in collaboration with Fengqiang Li.  
 
4.2.5 Recording system set up for Neuronal activity study (this work was carried out 
as a team project with Fengqiang Li from Dr. Chou Zhou’s group and undergraduate 
students: Marko Chavez, Jennifer Finley, Emma Galarza, Chelsea Serrano, and Victor 
Aguero. 
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Figure 21 Perfusion-OCM system set-up. (a) The set-up image of the integrated electrical and optical 
recording system. (b) The scheme of perfusion-OCM system in details. 
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Perfusion-OCM system set up 
Perfusion system was set up as shown in Figure 21a. In the perfusion system, as shown in  
Figure 21b., slices were placed in the middle of the recording chamber (RC-27, Warner 
Instruments, USA), submerging into the continual flowing ACSF with oxygen. 
Temperature, controlled by a heater controller (TC344, Warner Instruments, USA), was 
extremely crucial in this system to keep brain slices healthy. ACSF solution was initially 
warmed up by the preheater (controlled by the preheating control 1 of the heater) before 
it flowed into the recording chamber. In addition, the temperature of the recording 
chamber was maintained by the chamber heater (controlled by the chamber heating 
control 2 of the heater). In order to stimulate neuronal activity, a stimulator (Model 2300, 
A-M SYSTEM, USA) with a bipolar electrode (TST33A001KT, World Precision 
Instruments, USA) was applied in this system. The neuronal activity was collected by a 
recording electrode (TM33A05, World Precision Instruments, USA), amplified by an 
amplifier (Iso-DAM8A, World Precision Instruments, USA), and digitalized by a 
LabVIEW program. In addition, a sliver reference electrode was also placed in the 
recording chamber during electrical recording. Beneath the transparent recording 
chamber was placed an objective of the OCM system (constructed by Fengqiang Li from 
Dr. Zhou’s Lab) for brain slice imaging during electrical recording. The imaging signals 
were also processed by the LabVIEW program. 
  
Noise Optimization 
Initially, electrical noise of the perfusion-OCM integrating system was up to 0.7 mV 
when we turned on all equipment of the system, including the laser transmitter, the galvo 
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scanner, the heater, the amplifier, the stimulator and the computer. We could not collect 
neuronal activity signals in such a noisy recording environment. In order to find out the 
source of the interference signals, we carried out eleven trials of electrical recording 
under different combinations of equipment on and off, including the preheating control 1 
of the heater, the chamber heating control 2 of the heater, laser transmitter and galvo 
scanner. In trials when we turned off the heater, the noise level was significantly reduced. 
We figured out that the heater was the source of noise because alternating current was 
used to provide the system with constant temperature. We then grounded the heater and 
covered the majority of the equipment with aluminum foil. The noise level was brought 
down to 26 µV.  
 
Temperature Optimization 
Maintenance of temperature at 35 oC in the recording chamber was crucial in keeping 
brain slices healthily producing neuronal activity. The chamber heating control 2 was 
used to maintain the temperature of the recording chamber. However, ACSF solution 
with oxygen flowing into the chamber would change the temperature in the recording 
chamber, although it passed through the preheater (controlled by the preheating control 1 
in the heating apparatus) before flowing into the chamber. In order to maintain the 
temperature of 35 oC in the recording chamber, the combination of the temperature 
setting of preheating control 1, the temperature setting of chamber heating control 2 and 
the flow rate of ACSF was tested systematically. We firstly divided the chamber into five 
subsections. Then we applied different flow rates of 20, 24, 80, 88, 127 and 169 ml/h to 
the system to find out the best flow rate for maintaining constant temperature of 35 oC at 
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the middle of the chamber. If the flow rate was too slow, it can not keep the brain slices 
healthy due to depletion of oxygen. However, if the flow rate was too fast, the 
temperature would change a lot during ACSF flowing pass the chamber. Finally, we 
averaged the recorded temperature under different conditions from the five subsections to 
determine which combination was optimized. The combination of the preheating control 
1 of 42 oC, the chamber heating control 2 of 40.5 oC, and the flow rate of 127 ml/h was 
chosen to be the optimized parameters for temperature maintenance. 
 
Stimulation Optimization 
During stimulation, if the amplitude and the pulse duration of the stimulating current 
source were not proper, electrolysis, separation of the water molecules, would occur in 
the solution, causing damages to the recorded brain slice. In order to avoid this, the 
optimized working electrical charge, product of input current and pulse duration, needed 
to be determined. In the experiment, the stimulation artifact was outputted by the 
stimulator via biphasic current source, as shown in Figure 22, including positive 
discharge component (+) and negative discharge component (-). The amplitude of current 
source was able to be adjusted on the stimulator. The total duration of the pulse (on/off) 
and the duration of the positive discharge component (+) could also be adjusted via the 
LabVIEW control system. We initiated our experiments with the total duration of 10 ms 
(the duration of the positive discharge was 1 ms), and during this pulse duration we 
applied different stimulating current (around 200 µA) to see if electrolysis occurred. Then 
we decreased the total duration gradually, and we applied different stimulating current as 
described earlier within this total duration. In order to observe stimulated neuronal 
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activity, the input current should be above 150 µA. Our experiment results showed that 
the 170 µA and 8 ms with 1 ms positive duration could provide optimized stimulation 
without causing electrolysis. In addition, we could also obtain optimized electrical 
positive charge of 170 nC (product of 170 µA × 1 ms). 
  
 
 
Figure 22 Stimulation control. In real-time recording, output stimulating current was converted into 
stimulating voltage in stimulation artifact. Biphasic stimulating current was applied in the recording with a 
total duration (on/off), including a positive discharge duration (+) and a negative discharge duration (-). 
 
   
Once the optimized stimulating parameters were determined, we needed to evaluate the 
status of the brain slices during the stimulation. In order to observe significantly neuronal 
activity, we want to applied input current above 200 µA. Avoiding excess the electrical 
positive charge of 170 nC, we applied 1 ms total pulse duration (on/off) with 0.1 ms 
positive discharge duration in the brain slice stimulation. In this experiment, we applied 
different currents, ranging from 100 (the initial stimulating current) to 500 µA with the 
intervals of 100 µA, to the brain slice and recorded the neuronal activity, as shown in 
Figure 23a. Results showed that neuronal activity was very sensitive to the stimulating 
currents. The neuronal activity increased with the increase of the stimulating currents, 
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and when the current went back to 100 µA neuronal activity just went down to the initial 
state. In Figure 23b, it was the zoom-in period during 400 µA current input, and mini 
seizure like neuronal activity was observed, suggesting neurons were alive under this 
applied current source. In all, it was indicated that our perfusion system could be used to 
studied neuronal activity.  
 
 
 
Figure 23 Neuronal activity response to different stimulating current signal. (a) Electrical recording at 
different amplitudes under 1.0 ms total duration (on/off) and 0.1 ms positive discharge duration (+). (b) 
Electrical recording of evoked micro-seizures with stimulation of 100 µA, a positive stimuli duration of 0.1 
ms and a total duration of 1.0 ms. 
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Neuronal activity study 
Before recording, slices were transferred to the recording chamber. An electrode was 
placed at the CA1 neuron layer, as shown in Figure 24a, to collect LFP signals. In order 
to study neural circuits, a stimulating bipolar electrode was used to stimulate the brain 
slice at the neuropil closed to the CA3 region, and a recording electrode was placed at the 
CA1 neuron layer, as shown in Figure 24b, c and d. At the same time, OCM was used to 
record the optical intensity data and construct 3D image of the recorded brain slices, also 
shown in Figure 24b (en face image), c and d (cross-section images).  
 
 
 
Figure 24 OCM images of a brain slice when its neuronal activity is recorded by a recording electrode and 
it is stimulated by a bipolar electrode. (a) A representative microscope image of a brain slice in the OHC 
model on DIV 12. (b) The OCM image of the brain slice on DIV 12. (c) and (d) are cross-sectional OCM 
images of the brain slice with stimulation and recording electrodes into it. 
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4.3 Results 
 
4.3.1 Cell Counting and validation by OCM and confocal images (OCM system was 
built and made available for this project by Dr. Chao Zhou and Fengqiang Li). 
 
We firstly confirm that OCM images can produce the same quality neurons images 
compared to confocal images. As shown in Figure 25a, the whole slice OCM image is 
presented, and especially Figure 25c is a zoom in area of the OCM image of the whole 
slice, In comparison, the confocal image of the same slice after OCM imaging is 
presented in Figure 25b, and Figure 25d is also the same zoom in areas with the same 
layer. In the confocal images of Figure 25b and d, the cells were shown as the bright dots 
with dark background of the slice due to anti-NeuN immunostaining. However, due to 
different refractive index, cells in OCM image were observed as hyperscatteringly dark 
dots, as shown in Figure 25a, and this observation was consistent with previous work [96, 
97]. This hyperscattering could be partially attributed to the relatively homogeneous 
refractive index property within the neuronal nuclei [98]. In the same zoom in area at the 
same layer, as shown in Figure 25c and d, the same individual cells in the OCM image 
were found to match those in the confocal image.  
 
We used MATLAB algorithm to do cell counting, and compared the number of neurons 
imaged by the confocal microscopy and the number of neurons in the OCM images, as 
shown in Figure 26. In order to investigate the details of validation between OCM images 
and confocal images, we divided the whole slices into four quadrants, as shown in Figure 
26a and b. Specifically, morphology and numbers of neurons observed from the same 
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quadrants of both OCM and confocal images were thoroughly compared, as shown in 
Figure 26c and d. By using the designed MATLAB algorithm each neuron in these 
images was marked as a red dot, as shown in Figure 26e and f,  and we obtained a high 
correlation of 0.89 (Figure 26g). In addition, we compared numbers obtained from the 
detailed comparison of cell counts in the OCM and the confocal images. 200, 243, and 
303 cells were counted in the both imaging modalities from the three matching brain 
regions, respectively. However, due to different images methods, there were 72, 79, and 
67 cells identified from the OCM images only, while 55, 82, and 93 cells were identified 
from the confocal images only from the three regions, respectively. Table 1 summarized 
the comparison results. By analyzing these results, if considering cells identified from the 
confocal microscopy as the gold standard, we obtained a sensitivity of 76.4% from the 
OCM images to identify neurons. 23.6% of neurons, as the false negative rate compared 
to the confocal microscopy were missed in the OCM images. This could be partly 
attributed to the limited resolution of the OCM to differentiate small and clustered 
neurons (e.g., the lower left quadrant of Figure 26a) and imperfect match in depth for the 
OCM and the confocal images (when we prepare samples for confocal images, the same 
slices had been slightly distorted by fixation prior to immunostaining). As to the false 
positive cell count from OCM, this could be explained that some glial cells were also 
detected by the OCM images because sometime it is very hard to tell apart neurons and 
glial cells just by morphology, while in confocal images, some neurons were not stained 
with the anti-NeuN and, thus, not appearing in the confocal counts. Furthermore, 
counting errors of the algorithm could be another reason to making cell counting 
differences between OCM images and confocal images. 
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Figure 25 UHR-OCM image (a) and confocal image (b) from the same organotypic hippocampal culture on 
DIV 7. (c) and (d) are magnified images of regions indicated by brown rectangular boxes in (a) and (b), 
respectively. Circles in (c) and (d) highlight corresponding individual neurons in OCM and confocal 
images. Scale bars: 400 µm in (a) and (b), 100 µm in (c) and (d).  
 
Table 1 Comparison of number of cells identified in confocal and optical coherence microscopy (OCM) 
images from three matching brain regions. 
 
 
 Cells identified in confocal Cells not identified in confocal 
Cells identified in OCM 746 218 
Cells not identified in OCM 230 - 
Sensitivity 746/(746+230) × 100% = 76.4% 
False negative rate 230/(746+230) × 100% = 23.6% 
Positive predictive value 746/(746+218) × 100% = 77.4% 
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As a result, a positive predictive value of 77.4% was obtained. Although compared to 
confocal images cell identification, there are still some inevitable miss counting in OCM 
images, given the fact of that OCM images obtain neuron images based on intrinsic 
scattering, these results could be used to demonstrate that UHR-OCM could be used to 
provide relatively viable cell count in brain slices without the destructive fixation and 
staining processes involved using standard confocal microscopy. The imaging time for 
UHR-OCM is also short (a few minutes for each 3-D stack), making high-throughput 
evaluation of the samples possible using OCM.  
 
 
 
Figure 26 Correlation of neuron counts based on the OCM and the confocal images. Corresponding OCM 
image (a) and confocal image (b) from the same organotypic slice on DIV 7. Brown dashed lines split the 
OCM image and the confocal image into four quadrants. (c) and (d) show the lower right quadrant of the 
OCM image in (a) and the confocal image in (b), respectively. (e) and (f) label well-defined neurons as red 
dots in OCM and confocal images, respectively. (g) Regression line showing linear correlation (R2 = 0.89) 
between neuron count obtained from OCM and confocal images. Scale bars: 400 µm in (a) and (b) 200 µm 
in (c) to (f).  
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4.3.2 Neuron death in OHC observed by UHR-OCM  
 
 
Figure 27 OCM is used to study neuron death in OHC model. Representative OCM images are obtained 
from different cultures on (a) DIV 7, (b) 14, (e) 21, and (f) 28, respectively. The representative OCM 
images were obtained from a depth of around 50 µm from the slice surface. (c), (d), (g), and (h) are the 
magnified images of the brown rectangular regions in (a), (b), (e) and (f), respectively. Viable neurons are 
marked as red dots. (i) Total viable neuron counts from the first 150 µm of the organotypic hippocampal 
cultures from different DIVs. ***p < 0.001. Scale bars: 400 µm in (a), (b), (e) and (f), 200 µm in (c), (d), 
(g), and (h). 
 
In this experiment, UHR-OCM imaging was used to investigate the neuron death in 
hippocampal brain slices from DIV7 (n = 18), DIV 14 (n = 11), DIV 21 (n = 18), to DIV 
28 (n = 9) in order to observe the progression of neuronal injury. As shown in Figure 27a 
to h, cell counting of representative en face OCM images from slices on different DIV. 
Especially, Figure 27e to h showed more clearly that neuron boundaries became diffusive 
and the image contrast was reduced as DIV increased, suggesting the membrane integrity 
of some neurons in the slice cultures was compromised. Cell counting from the same 
slices on different DIVs were compared. Figure 27i summarized cell counting results and 
compared the results, presenting that the number of viable cells significantly decreased 
with the increased DIV. Compared to DIV 7, significant reductions in cell counts of 
23.1% (p < 0.001), 33.7% (p < 0.001), and 45.8% (p < 0.001) were observed on DIV 14, 
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21 and 28, respectively, suggesting neuronal injury was highest during this time period 
around DIV 14 with higher reduction rate, in accordance with our former LDH results. 
 
In addition, measurements of slice thickness on different DIVs also showed continuous 
decreases in both the CA1 and the CA3 regions as DIV increased, as shown in Figure 28a 
to d, and quantification results were shown in Figure 28e. In CA1, reductions in slice 
thickness of 1% (p = 0.82), 12% (p < 0.001), and 19.3% (p < 0.001) were observed on 
DIV 14, DIV 21 and DIV 28, respectively, while in CA3, reductions of 2.7% (p = 0.54), 
13.5% (p < 0.001), and 16.1% (p < 0.001) were observed on DIV 14, DIV 21, and DIV 
28, respectively. The decreasing trend in slice thickness was consistent with the trend in 
cell counts as DIV increased, suggesting that death rate of neurons was associated with 
the decrease of brain slice thickness. The percentage of thickness reduction was less than 
the cell count reduction, indicating that neuron loss may not be the only mechanism that 
contributes to changes in slice thickness with culture age.  
 
Figure 28 OCM is used to study neuron death based on the change of brain slice thickness. (a) to (d) 
Representative cross-sectional OCM images obtained from the CA3 region on different DIVs. (e) 
Thickness of brain cultures on different DIVs in CA1-sub and CA3 regions, respectively. *** p < 0.001. 
Scale bars: 200 µm. 
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4.3.3 Evaluation of treatment effects of KYNA to hippocampal slice cultures 
 
Our previous work has demonstrated that seizures occur spontaneously in organotypic 
hippocampal slice cultures, leading to neuron death. Kynurenic acid (KYNA), as an 
anticonvulsant drug, is efficient in reducing ictal activities and surviving neurons in the 
brain slices [99]. In Figure 29a to h neuron counts of representative en face OCM images 
obtained from the control and the KYNA treated brain slices on DIV 7 (n = 9) and DIV 
21 (n = 9), respectively, were compared. In the control group, significantly fewer cells 
with well-defined boundaries were observed on DIV 21 (n = 9) compared to DIV 7 (n = 
9), as shown in Figure 29a to d. In parallel, the reduction of well-defined cells in the 
KYNA group was less dramatic on DIV 21 compared to DIV 7 (Figure 29e to h) with a 
relatively small reduction rate. Figure 29i further presented the quantification result of 
cell numbers in the two groups and this also confirmed the observations from visual 
inspection of the OCM images. In Figure 29i, a significant reduction of 40.3% in cell 
counts (DIV 21 versus DIV 7, p < 0.001) was observed in the control group, while a 
reduction of 20.0% in cell count (DIV 21 versus DIV 7, p < 0.05) was observed in the 
KYNA treated group. Viable cell count was similar in the two groups on DIV 7 (p = 
0.35), but was significantly lower (19%), p < 0.05) in the control group compared to the 
KYNA treated group on DIV 21. 
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Figure 29 OCM is used to observe neurons preserved in KYNA treated groups and the comparison of the 
OCM images from the confocal group [(a) to (d)] and the kynurenic acid (KYNA)-treated group [(e) to (h)] 
is presented. (a) and (b), Representative OCM images obtained on DIV 7 and DIV 21, respectively, from 
the control group. (e) and (f), Representative OCM images obtained on DIV 7 and DIV 21, respectively, 
from the KYNA-treated group. (c), (d), (g) and (h) are the magnified images of the brown rectangular 
regions in (a), (b), (e) and (f), respectively. Red dots label viable neurons. (i) Total viable neuron count 
from the first 150 µm of slices on DIV 7 and DIV 21 in the control and the KYNA-treated groups. Number 
of cultures imaged n = 9 for each group on IDVs 7 and 21, respectively. * p < 0.05 and *** p < 0.001. 
Scale bars: 400 µm in (a), (b), (e) and (f), 200 µm in (c), (d), (g) and (h). 
 
In addition, since the OCM system is also good at cross-section imaging, it can be used to 
study the change of cross-sectional brain slice thickness images in different conditions. 
As it was shown in Figure 30a to d, slice thickness obtained from the representative 
cross-sectional OCM images from the CA3 regions of the brain slices from the control 
and the KYNA treated groups were compared. The result of the measurement of the slice 
thickness of the CA1 and CA3 regions, as shown in Figure 30e, was compared. It showed 
that the thickness of brain slice on DIV 21 was significantly smaller than that on DIV 7. 
In the control group, thickness reductions of 12.0% (p < 0.001) and 13.3% (p < 0.001) 
were observed in the CA1 and CA3 regions, respectively. In the KYNA treated group, 
thickness reductions of 8.6% (p < 0.05) and 8.0% (p < 0.05) were observed in the CA1 
 77 
and CA3 regions, respectively. The reduction of slice thickness was consistent with the 
trend observed in the cell counts. 
 
 
 
 
Figure 30 The change of thickness of the KYNA treated and the control groups are observed in OCM 
images. Representative cross-sectional OCM images of the control group [(a) and (b)] and the KYNA-
treated group [(c) and (d)] obtained from CA3 region on DIV 7 and DIV 21, respectively. (e), Culture 
thickness measurements on DIV 7 and DIV 21 in control and KYNA-treated groups in CA1-sub and CA3 
regions, respectively. * p < 0.05 and *** p < 0.001. Scale bars: 200 µm. 
 
Based on these experimental results of monitoring progressive neuron death and the 
neuroprotective effect of KYNA, we can conclude that UHR-OCM system is qualified to 
observe neural activities on brain tissue. In addition, these data obtained from OCM 
system are also in agreement with our previous observations that using confocal imaging 
of propidium iodide uptake and releasing LDH as the markers of neuron death. In return, 
UHR-OCM is further validated as a powerful tool for label-free, live evaluation of 
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organotypic brain cultures, especially in cell numbers counting and tissue slices thickness 
measurement. Compared to the confocal imaging, the UHR-OCM system can construct 
3-D imaging models in a much faster speed, and hence make it possible to investigate 3-
D tissue culture disease models for high-throughput drug discovery for disorders where 
evaluation of progressive changes in cell numbers is required. This work was carried out 
as a collaboration with Fengqiang Li and Prof. Zhou, and published in [92]. 
 
4.3.4 Stimulation activities under TTX presence/absence conditions 
 
Tetrodotoxin (TTX), as a drug to block sodium channel on cell membrane, is usually 
used to suppress neuron activities. In this experiment, we want to test whether the 
electrical signals recorded in the perfusion system are originating from neurons through 
TTX application to brain slices. Before TTX application, the recording system collect 
many neuronal activities, while after TTX application few neuron activities are supposed 
to be recorded. Brain slices on DIV 12 were transferred to the recording chamber of the 
perfusion system. A stimulation electrode (stimulating amplitude: 400 µA; pulse 
duration: 1 ms; positive charge duration: 0.1 ms; negative charge duration: 0.9 ms) was 
placed closed to the CA3 region and a recording electrode was placed on the CA1 region. 
The whole recording time was 1 hour, as shown in Figure 31a. After flowing ACSF 
solution without TTX at the first 20 min (Figure 31b), we flowed ACSF with TTX (0.5 
mM) into the chamber for another 20 min (Figure 31c). Then ACSF solution without 
TTX was flowed again to the end (Figure 31d). Neural activities were very sensitive to 
TTX and neural activities were almost muted during TTX flowing and disappeared even 
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if ACSF without TTX flowed again. This indicated that our perfusion system was very 
sensitive to different drugs applying on brain slices and hence could be used for drug 
screen study. 
 
 
 
Figure 31 Acute TTX application has obvious influence on neuronal activities. (a) Full time recording of 
acute TTX application experiment: –TTX ACSF flowed at the beginning for 35 mins; +TTX ACSF flowed 
successively after –TTX from 2800 s to 4600 s; from 4600 s to the end, –TTX ACSF flowed again into the 
recording chamber. (b) Neuronal activities zoom in at 2000 s to 2100 s. (c) No activites shown during TTX 
flowing, zoom in at 3800 s to 3900 s. (d) No activites shown after TTX flowing, zoom in at 5600 s to 5700 
s. 
 
Different optical intensities of neurons and neuropil after stimulation 
 
We used our integrated system (perfusion system and OCM system) to study light signal 
intensities of neurons and neuropil during stimulation recording. Compared to relatively 
rest neuropil signal, neurons are very active. This suggests that refractive index in 
neurons is quite different from that of surround neuropil. Considering the OCM system is 
good at capturing change in scattering, it is very promising to distinguish neurons and 
neuropil by OCM image. As shown in Figure 32a, we applied stimulation into recording.  
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Figure 32 OCM intensity analysis of neurons and neuropil during stimulation recording was presented. (a), 
Stimulation recording; (b), Zoom in area of stimulation recording in the red frame; (c), Merged intensity of 
10-epoch electrical recording during stimulation; (d), Average intensity of 10-epoch electrical recording 
signals; (e), Merged optical intensities of 10-epoch OCM imaging of neuropil; (f), Average optical intensity 
of 10-epoch OCM imaging of neuropil; (g), Merged optical intensities of 10-epoch OCM imaging of 
neurons; (h), Average optical intensity of10-epoch OCM imaging of neurons. 
 
According to Figure 32b, neural activity was stimulated by stimulation pulse. Then we 
merged 10-epoch recordings and average intensity of electrical recording, as shown in 
Figure 32c and d. During stimulation and electrical recording, we also used the OCM to 
investigate optical intensity of neurons and neuropil. Optical intensity were collected 
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before and after stimulation with a period of 6 s. 10-epoch optical intensities of neuropil 
were merged and averaged, as shown in Figure 32e and f. 10-epoch optical intensities of 
neurons were merged and averaged, as shown in Figure 32g and h. Compared to optical 
signals from neuropil with a small scale, optical signals from neurons oscillate in a large 
scale, suggesting that neurons have different OCM intensity from that of neuropil during 
stimulation. This work was carried out in collaboration with Fengqiang Li. 
 
4.4 Summary of chapter 4 
 
In summary, we developed an UHR-OCM system with micrometer image resolutions to 
image individual neurons in rat organotypic hippocampal cultures. A neuron counting 
algorithm based on MATLAB was developed to quantify neuron number in the 3D OCM 
and the confocal images and a good linear correlation (R2 = 0.89) in neuron count was 
obtained by using the two imaging modalities. With the UHR-OCM, we observed 
significant reductions in neuron count and culture thickness induced by spontaneous 
seizures. In addition, we further applied KYNA to reduce seizure-dependent neuron death 
and this neuroprotection experiment was systematically observed by using the OCM 
system. These results demonstrated UHR-OCM as a promising 3D imaging tool could be 
used for high-throughput label-free and non-destructive characterization of micron-scale 
morphological changes in organotypic hippocampal cultures and potentially other organ-
on-a-chip or 3D tissue constructs. 
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Significantly different signal responses of brain slices to TTX short-term treatment had 
been verified by the integrated OCM and perfusion system. The designed system was 
very sensitive to neuron activities changes, making it as a powerful tool in neuronal 
activities study. In addition, different OCM intensities of neurons and neuropil during 
stimulation recording had also been verified by the integrated recording system due to 
their different refractive index during stimulation. Compared to relatively quiet neuropil 
signals, neurons were very active during stimulation, and this result was also in 
accordance with our electrical recording, suggesting that the designed system was reliable 
in neuronal activities study. 
 
4.5 Future Work 
 
4.5.1 2D neural circuit electrophysiological recording and OCM imaging 
 
Channelrhodopsin2 with YFP was encoded into neuron membranes. Firstly, we will use 
patch clamp to figure out intensity and pulse width of excitation light. Neurons are 
cultured on coverslips. After several days’ incubation, 2D neural circuits are formed on 
the coverslip. Then we will transfer these neurons to the platform of OCM system. Once 
we apply the excitation light to the 2D neuron circuits, OCM system will observe the 
refractive index changes of neurons and hence imaging the 2D neural circuits.  
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4.5.2 3D neural circuit electrophysiological recording and OCM imaging 
 
Slices treated with optogenetic gene virus vectors will be cultured for a while before 
OCM imaging. Based on the OCM imaging results accumulated from 2D neural circuit 
investigation, 3D neural circuits will render a more complex neural circuit 
communication network through OCM imaging. From this network study, we will 
understand how neural activities propagate and develop. Specially, we can observe the 
development of epilepsy from the real-time OCM imaging. Monitoring the development 
of epilepsy, we will understand how epileptogenesis occurs in a tissue level and therefore 
we designed efficient drug targeted area in brain instead of application of drug across the 
whole brain. 
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5. Other smaller projects done during Ph.D. study 
 
5.1 Investigation of Homeostatic Plasticity at Electrical Synapses  
(this work was carried out in collaboration with Dr. Julie Haas in the 
Department of Biological Sciences at Lehigh). 
 
 
5.1.1 Background 
 
There are two major synapses in neurons: chemical synapses and electrical synapses. 
Compared to chemical synapses which rely on released chemical transmitters, electrical 
synapses depend on ionic current flowing directly between neurons via gap junctions of 
neighbor neurons. In order to response to global activity modulation, chemical synapses 
can usually be modified due to network activity manipulation and this modification of 
chemical synapses is called as homeostatic plasticity. Although electrical synapses can be 
modified in many ways [100-102], whether or not modification of electrical synapses by 
homeostatic plasticity raise a hot debate and is still elusive.  
 
In this project, organotypic hippocampal culture was used to provide gap junction-couple 
interneurons and the dual whole-cell patch clamping was used to stimulate and record 
neurons activities (whole-cell recording experiments were carried out by Prof. Haas’s 
group). In addition, tetrodotoxin (TTX), a sodium channel blocker, was used to silence 
network activity. Increasing strength of neural activities will be observed in the TTX-
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treated slices compared to the control slices if homeostatic plasticity in regulation of 
electrical synapses. 
 
 
5.1.2 TTX-treated OHC slices prepared 
 
Hippocampal slices with a thickness of 350 µm were dissected from the hippocampus of 
7 days old Sprague-Dawley rats. After dissection, half slices were maintained from 0 
DIV with the TTX-treated nutrition medium which includes Neurobasal-A, GlutaMax 
(0.5 mM), Gentamicin (30 µg/ml), insulin (175 mg/L), sodium selenite (Se) (14 ng/ml) 
and bovine serum albumin (BSA) (250 µg/ml) and TTX (1 µM) (all from Life 
Technologies); while another half of slices were maintained from 0 DIV with only 
nutrition medium, as shown in Figure 33. In addition, these slices were stored in an 
incubator with humidified 5% CO2 and temperature of 37 
oC. On DIV 4, slices were 
transferred to the recording platform of the dual whole-cell patch clamping equipment for 
activity recording. 
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Figure 33 Microscope images of TTX treated and control slices on DIV 5. Compared to the control slices, 
the slices treated by TTX seemed to be degraded. 
 
 
5.1.2 Measurement of electrical synapses strength to be modified homeostatically 
 
Experimental brain slices were cultured in the TTX-treated media and the control media 
for 4 DIVs. If electrical synapses can be modified by homeostatic plasticity, increasing 
strength of the TTX-treated slices will be observed compared to the control groups after 
removing TTX media.   
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Figure 34 Electrical coupling strength (CC) is not significantly different between control and TTX-treated 
pairs of cells. This figure was contributed by Emily Heckman, Sarah Fittro, and Jessica Sevetson from Dr. 
Haas’s group. 
 
In this experiment, paired whole-cell recordings firstly verify that there are electrical 
synapses preserved in the OHC model. However, not homeostatically modified synaptic 
strength was observed, as shown in Figure 34. This result may be attributed to some 
experimental concerns. The concentration of TTX may be too toxic to the brain slices. 
Since brain slices underwent such a harsh environment, some mechanism was inhibited. 
In addition, it was very hard to find paired neurons which both absorbed TTX. In future, 
in order to demonstrate homeostatic plasticity in neurons, TTX concentration can be 
modified and more experiments can be carried on. This work was the result of a 
collaborative effort with Emily Heckman, Sarah Fittro, and Jessica Sevetson from Dr. 
Haas’s laboratory.  
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5.2 Cell capture based on PDMS microfluidic chips 
(this work was carried out in Dr. Yaling Liu’s lab in the Department of 
Mechanical Engineering & Mechanics at Lehigh) 
 
5.2.1 Background and objects 
 
With the development of point-of-cure techniques, cell capture technique attracts 
increasing attention from many research areas, including medicine, biology and 
engineering. Especially in cancer therapy researches, in order to further understand 
pathogenesis and increase therapies efficiency, it is necessary to isolate a small amount of 
cancer cells, even a single cancer cell, from real body fluids, in particular, from human 
serums, for specific targeted researches. This requires a corresponding rapid development 
in relevant devices industries. Hence, many advanced lab-on-a-chip techniques in cell 
capture came out and developed rapidly. 
 
In my study, I focused on realizing the cell capture by PDMS microfluidic chips with 
different patterns. Patterns of these chips were wave, herringbone, and wave herringbone 
with size ranging from several micrometers to several hundred micrometers. In addition, 
influences of different shear rates and particles sizes on capture efficiency are also 
investigated in our experiments. Before cell experiments, nanoparticles, as substitutes, 
with different sizes were tested. Our goal was to find a best capture efficiency and 
particle distribution under a condition with a certain channel pattern, size and shear rate. 
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5.2.2 Materials and methods 
 
Wave, herringbone and wave herringbone patterns with 20 µm and 40 µm were 
fabricated as described followed. Liquid PDMS and its curing agent with mixed ratio of 
10:1 were prepared. Before placed in a dessicator, the mixed colloid was stirring evenly, 
with fine bubbles. Generally speaking, 20 ml liquid PDMS was used to prepare for 4 to 5 
chips. Then the colloid was placed in the dessicator for 30 minutes for debubbling. Every 
5 minutes, there was inflation, getting rid of bubbles more quickly. Then liquid PDMS 
with curing agents was poured on to the wave and wave herringbone patterns. In order to 
reduce the roughness of surfaces (let bubbles more easily go out of PDMS) and to 
maintain flat interface, the thickness of PDMS was normally 2 to 3 mm. When aluminum 
foils were used to wrap patterns, the substrates were suggested to be wrapped tightly, 
avoiding liquid PDMS influx when solidification. Then patterns were placed in the 
dessicator for 10 minutes for debubbling. Liquid PDMS on patterns, after getting rid of 
bubbles, was further placed in a baker. The temperature was set at 100 oC for 10 to 15 
minutes. After solidification, the PDMS with patterns on them were trimmed. Due to less 
marginal areas of 20 µm wave patterns, side cut was needed. This enlarged the marginal 
areas for subsequent oxygen plasma binding. After punching two holes in the cover 
pattern, the covers and the patterns with wave and wave herringbone were binding by 
using oxygen plasma. Then 5% saline solution was used to modify the inner walls of 
channels. This saline provided thiol group on the inner walls. Every 10 minutes, saline 
was reinjected into the devices. After repeating previous steps 3 to 4 times, pure ethanol 
was used to clean unbinding thiol groups in the channel. Then the devices were placed in 
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the baker for 5 to 10 minutes. N-[γ-maleimidobutyryloxy] succinimide ester (GMBS) was 
further used to modify thiol groups in the channels. Incubation with covers was 30 
minutes. Deionized water was used to flush unbinding GMBS. NeutrAvidin (NA) 
solution was filled into the channels and NA was caught by GMBS. Then the devices 
were incubated and after overnight incubation devices were ready for testing. 
 
Particles capture experiments in the wave patterns were briefly described below. The flux 
used in the experiment was 3542 ml/hr. The shear rates of 200 /s 100 /s, 60 /s and 15 /s 
were tested, respectively. Patterns sizes of 20 µm and 40 µm were applied and the 
particles sizes were 10 µm and 20 µm. The testing time was 15 min and the temperature 
was controlled at 20 oC. 
 
5.2.3 Preliminary Data 
 
Figure 35 showed the research results of 10 µm and 20 µm particles capture at different 
shear rates of 200 /s, 100 /s, 60 /s and 15 /s in 40 µm wave pattern. Figure 35a and b 
indicated few particles were immobilized by the wave pattern due to relative high shear 
rates. Although Figure 35d shows that some particles were immobilized, the amount of 
binding particles were still smaller than that in a shear rate of 60 /s, as shown in Figure 
35c. Low shear rate is good for particles immobilization, but amount of particles are also 
reduced. Hence, in order to increase amount of binding particles without reducing 
binding efficiency, certain shear rate, in this case 60 /s, is the best choice for this balance. 
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Figure 35 Comparison of particles with different sizes capture experiment under different shear rates in the 
40 um wave pattern.10 µm and 20 µm particles in 40 µm wave pattern with different shear rates : (a) 200 
/s, (b) 100 /s, (c) 60 /s and (d) 15 /s.    
 
 
 
Figure 36 Comparison of particles with different sizes capture experiment under different shear rates in 20 
µm wave pattern.10 um and 20 um particles in 20 µm wave pattern with different shear rates : (a) 200 /s, 
(b) 100 /s, (c) 60 /s and (d) 15 /s. 
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Figure 36 showed the research results of 10 µm and 20 µm fluorescent particles capture 
at different shear rates of 200 /s, 100 /s, 60 /s and 15 /s in 20 µm wave pattern. Figure 36c 
shows that particles in a shear rate of 60 /s are more efficient to bind on the wave patterns 
than particles in other shear rate of  200 /s (Figure 36a), 100 /s (Figure 36b), and 15 /s 
(Figure 36d). Both 10 µm and 20 µm particles were tending to stay at the bottom of the 
wave patterns. Compared to 10 µm particles, 20 µm particles have more trends to 
immobilize. The capture efficiency for shear rate of 60 /s is 20%.   
 
5.2.4 Discussion and conclusion 
 
It is very hard to bind the covers and the patterns very well when the roughness of the 
surface was too bad, by oxygen plasma, leading to leakage during subsequent 
modification. This was attributed to the variant surface situation of negative molds or the 
inner stress of solidified PDMS. Hence, in order to obtain fully closed microfluidic chips 
chambers, roughness of patterns needed to be controlled via controlling both of 
temperature and baking time when liquid PDMS solidify.   
 
Based on analysis of these experiments, a shear rate of 60 /s and a wave pattern size of 20 
µm are the best conditions for 10 µm and 20 µm particles to immobilize on the modified 
surface of microfluidic chips. These particles tend to immobilize on the bottom of these 
wave patterns, and the efficiency is 20%.  
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5.3 Shrink-film microfluidic devices fabrication 
(this work was carried out in Dr. Yaling Liu’s lab in the Department of 
Mechanical Engineering & Mechanics at Lehigh) 
 
5.3.1 Background and objects 
 
Shrink-film technology applied in microfluidic devices fabrication will greatly improve 
efficiency of fabrication. When shrink-film is treated on a certain temperature, the film is 
going to shrink and to form the required patterns, and then this shrunk film can be served 
as a mold for fabricating devices patterns via soft lithography technology. In addition, 
both of the equipment used and experimental skills are not sophisticated, and it is easy to 
carry out under any experimental conditions. Based on these advantages, shrink-film 
technology has become a popular fabrication method in lab-on-a-chip researches. 
In our experiments, we used shrink-film to fabricate 20 µm and 40 µm wave patterns. 
Consider heating temperature plays an important role in film shrinking. We first 
investigated film shrinking ratios under different temperatures to find a best shrinking 
temperature. Then the shrunk films were applied to form even wave patterns. Then we 
fabricated our microfluidic chips with certain patterns under this experimental condition. 
 
               [1] 
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5.3.2 Materials and methods 
 
Shrink-film 955D is used in our experiments. We cut film into pieces then placed them 
evenly on a silicon plate heated on a heating plate. The temperature applied was ranging 
from 80 oC to 155 oC and the heating time was from 5 minutes to 20 minutes. 
 
Process of applying shrink-film for devices fabrication is briefly described as followed. 
The targeted patterns were constructed via Auto CAD. Multilayers shrink-film was taped 
on an unshrunk backer. Patterns were printed on the shrink-film by a normal laser printer. 
The shrink-film was pinned on several specific points to make the alignment between 
different layers. Then the multilayer structures were placed on a silicon plate and heated. 
The shrink film would be shrunk and a shrink-film mold with required pattern was 
obtained. 
 
5.3.3 Partial results and discussion 
 
We prepared pieces of shrink-film with size of 3 × 3 cm2 and the lattices were drawn on 
these pieces by an oily pen. We measured the sizes of these pieces before and after 
heating, as shown in Figure 37. Sequent experiments were designed to investigate the 
relationship between shrink ratios and heating temperature and time. Shrinking ratios 
under different heating temperature (80 oC, 100 oC, 120 oC, 135 oC and 155 oC) and time 
(5 min, 10 min and 20 min) were obtained by comparing their length before and after 
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heating. The results, shown in Table 2, indicate that shrinking radios is the smallest with 
a value of 62.22% when the temperature is 155 oC and the heating time is 10 min.  
 
 
 
Figure 37 Comparison between pieces of shrink-film before and after heating. 
 
 
Table 2 Experimental results of the shrink-film shrinking rates. 
 
Shrinking ratios 
Temperature (oC) 
80 100 120 135 155 
Time (min) 
5 94.67% 93.02% 91.11% 95.24% 78.17% 
10 92.10% 90.90% 88.89% 86.97% 62.22% 
20 88.16% 89.47% 90.70% 94.29% 71.42% 
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6. Conclusion 
 
6.1 Spontaneous Ictal Activities Induced by IGF-1 Signaling Cascade 
 
We first determined the optimal concentration of IGF-1 for our experiment was 152 ng/L 
(20 nM). Following short term IGF-1 neuroprotection evaluation experiments from DIV 
0 to DIV 3, long term exposure to IGF-1 was investigated by neuron survival rate, 
electrophysiological recording, LDH test, and Lactate test. These results concluded that 
prolonged IGF-1 application would lead to increased ictal activities. In addition, temporal 
effects of IGF-1 regulation in neuron signaling cascades, especially the PI3K-Akt-mTOR, 
starts at around 30 mins after IGF-1 treatment. This timing effect allowed the study how 
IGF-1 regulates signaling cascade in acute application. The results showed that acute 
application of IGF-1 had no effects in epileptogenesis. Furthermore, signaling cascades 
activated by the phosphorylation of IGF-1 receptor were studied by western blotting. The 
signaling cascade of PI3K-Akt-mTOR had been demonstrated to play an important role 
in epileptogenesis, and increased protein synthesis rate was discovered in +IGF-1 treated 
groups. In all, this series of experiments concluded that short term application of IGF-1 
just after injury promote neuron survival while long term application of IGF-1 leads to 
severe ictal activities and neuron death by activating the PI3K-Akt-mTOR cascade. 
 
6.2 Using Small interfering RNA (siRNA) silencing to inhibit epileptic pathway 
 
250 µm thick brain slices uptake siRNA and allow for long-term culture study. In 
addition, cofilin, which is related to axon sprouting, was successfully targeted by specific 
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cfl1-siRNA. Reduced expression of cofilin was further verified by western blots results in 
an OHC model. However, axons length and density of axons around brains slices have no 
significant difference in the cfl1-siRNA treated groups and the non-targeting siRNA 
treated control groups, and the Lactate and LDH results of two experimental groups 
further put cofilin in a controversial debate, suggesting that there was weak connection 
between cofilin driving axon growth and epileptogenesis. According to these results, 
other actin binding proteins may replace cofilin when cofilin was knocked down in the 
experiment. In order to further confirm the relationship between cofilin expression and 
epileptogenesis, optogenetics technology is encouraged to be applied into investigation of 
axons growth of inner neurons of cfl1-siRNA treated brain slices.  
 
6.3 Electrical recording system integrated with OCM technology 
 
We developed an UHR-OCM system with micrometer image resolutions to image 
individual neurons in rat organotypic hippocampal cultures. A neuron counting algorithm 
based on MATLAB was developed to quantify neuron number in the 3D OCM and 
confocal images and a good linear correlation (R2 = 0.89) in neuron count was obtained 
by using the two imaging modalities. With UHR-OCM, we observed significant 
reductions in neuron count and culture thickness induced by spontaneous seizures. In 
addition, we further applied KYNA to reduce seizure-dependent neuron death and this 
neuroprotection experiment was systematically observed by using the OCM system. 
These results demonstrated UHR-OCM as a promising 3D imaging tool could be used for 
high-throughput label-free and non-destructive characterization of micron-scale 
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morphological changes in organotypic hippocampal cultures and potentially other organ-
on-a-chip or 3D tissue constructs. 
 
Significantly different signal responses of brain slices to TTX short-term treatment had 
been verified by the integrated OCM and perfusion system. The designed system was 
very sensitive to neuron activities changes, making it as a powerful tool in neuron 
activities study. In addition, different OCM intensities of neurons and neuropil during 
stimulation recording had also been verified by the integrated recording system due to 
their difference refractive index during stimulation. Compared to relatively quiet neuropil 
signals, neurons were very active during stimulation, and this result was also in 
accordance with our electrical recording, suggesting that the designed system was reliable 
in neuronal activities study. 
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List of collaborators 
1. The work that estern blotting was used to investigate how IGF-1R 
phosphorylation regulates PI3K and MAPK signaling cascades (Figure 10) was 
contributed by Lauren Boller, Katherin Walters and Corrina Lucini. 
2. The work that siRNA uptake in 250 µm thick brain slices (Figure 16) was 
contributed by Anna Sternburg. 
3. OCM system set up, cell counting and LabVIEW program in Chapter 4 were 
collaborated with Fengqiang Li from Dr. Chao Zhou’s Lab. 
4. The work that integrating perfusion system with OCM system was collaborated 
with Fengqiang Li, Marko Chavez, Jennifer Finley, Emma Galarza, Chelsea 
Serrano, Victor Aguero. 
5. The work that optimum intensity, pulse width and pulse frequency of exciting 
blue lights in a patch clamp recording system for infected neurons with 
channelrhodopsin2 (Ch2) was collaborated with Md Fayad Hasan and Aniruddha 
Ghosh. 
6. The work of homeostatic plasticity investigation was collaborated with Emily 
Heckman, Sarah Fittro, and Jessica Sevetson. 
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